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ABSTRACT 
Ventilation is higher at any submaximal workload in hypoxia as compared to normoxia.  
Whether or not training the respiratory muscles helps to improve exercise performance in 
hypoxia is unclear.  Purpose: To determine if improvements in ventilatory strength with chronic 
inspiratory muscle training (IMT) improves 20km cycling time trial (TT) performance in 
hypoxia (FIO2 = 16.1%).  Methods: Thirteen highly-trained men were pair-matched based on 
pre-exercise values of maximal inspiratory pressure (MIP) and randomly placed into either a 
sham (n = 5, V̇O2max = 61.7 ± 2.0 ml∙kg-1∙min-1) or an IMT (n = 8, V̇O2max = 63.5 ± 3.4 ml∙kg-
1∙min-1) group.  Subjects completed 6 weeks of flow resistive IMT (80% of MIP) or a sham 
protocol (30% of MIP), with each session consisting of up to 6 sets of 6 MIP maneuvers 
performed to failure with descending rest intervals 3 times per week.  Pre- and post-training, 
subjects performed tests of pulmonary function, lung volume, MIP, maximal expiratory pressure 
(MEP), lung diffusion capacity (DLCO), and a 20km cycling TT in hypoxia (FIO2 = 16.1%).  
Results: After 6 weeks of IMT or sham, the IMT group significantly improved MIP (127.6 ± 
13.4 cmH2O vs 159.0 ± 15.3 cmH2O, p < 0.05), while MIP in the sham group remained 
unchanged.  MEP, DLCO, lung volumes, and pulmonary function values remained unchanged in 
both groups post-training.  20km TT mean ventilation was significantly higher post-IMT (99.6 ± 
5.5 l∙min-1 vs 110.4 ± 6.8 l∙min-1, p < 0.05) and unchanged in sham.  20km TT mean breathing 
frequency was also significantly increased post-IMT (41.4 ± 2.8 b∙min-1 vs 45.1 ± 2.9 b∙min-1, p 
< 0.05) and unchanged in sham.  20km TT mean V̇O2 was significantly increased post-IMT (3.41 
± 0.19 L∙min-1 vs 3.61 ± 0.21 L∙min-1) and unchanged in sham.  In the IMT group, 20km TT 
performance time pre-training was 36.77 ± 1.40 (min) and post-training was 36.28 ± 1.24 (min) 
(-1.4 ± 1.9%, p = 0.06).  20km TT performance time was unchanged in the sham group.  20km 
TT heart rate and SpO2 were unchanged in both groups post-training.  Conclusion: In a small 
cohort, IMT-induced improvements in respiratory muscle strength which resulted in greater 
ventilation and oxygen uptake during a 20km time trial in hypoxia.  IMT should be explored as a 
useful strategy for improving the quality of cycle exercise training and/or endurance exercise 
performance at altitude.  
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Chapter I: Introduction 
 
Athletes competing in a hypoxic environment experience a worsening of exercise 
performance.   One of the main causes is a decline in arterial oxygenation which causes a decline 
in maximal oxygen consumption.  The body compensates for the decline in arterial oxygenation 
by increasing ventilation, which increases work of breathing.  During exercise in normoxia, it is 
estimated that the inspiratory muscles consume 10 to 15 percent of total body oxygen uptake (1).  
However, in hypoxia, the oxygen demand of the respiratory muscles increases an additional 20 to 
30 percent (2).  In response to an increase in work of breathing, the inspiratory muscles increase 
their oxygen supply by shunting blood away from the working muscle and to the inspiratory 
muscles (15).  Therefore, this causes a decrease in locomotor muscle power production and 
increases the rate of fatigue. 
There have been many different theories and techniques used to attenuate the effects of 
altitude on exercise performance.  Inspiratory muscle training (IMT) has been shown to increase 
performance during a cycling time trial of 20 km or longer in a normoxic environment (20, 34).  
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Interestingly, to our knowledge, there has only been one study examining the effects of IMT on 
performance in hypoxia.  In this study by Downey et al., IMT increased oxygen diffusing 
capacity and arterial oxygen saturation while decreasing ventilation, cardiac output and 
inspiratory muscle fatigue during a treadmill time to exhaustion test (TTE) in hypoxia (8).  Based 
on these results one would expect exercise performance in hypoxia to benefit from IMT, but 
there was no significant difference in the time to exhaustion test on a treadmill between the IMT 
and sham training groups.  A lack of significant difference in exercise performance in hypoxia in 
the Downey et al. study may be due to the specific performance trial used not being robust 
enough to detect differences.  The duration, for the experimental and control group, was 9.7 ± 
1.5 min and 7.4 ± 1.2 min, respectively.  To our knowledge, in IMT studies using running there 
has not been a significant performance difference for tests that have a duration of less than 15 
minutes (12, 22, 29).   
For this study, we used a cycling fixed distance time trial test as our performance variable 
in place of the treadmill TTE test.  TTE has been shown to not be as reliable (28, 43) or as 
applicable for competition (16) as a time trial.  During competitions, cyclists do not cycle at a 
constant work load thus performing a time trial where they can adjust their work load is a better 
simulation for competition.  Additionally, the length of the performance test used may be a factor 
in the Downey et al. study failing to show differences in performance after IMT.  IMT studies 
where the mode of exercise is cycling performed in normoxia has shown no significant 
improvement during a set distance time trial that was only 8 km (38), but when the TT was at 
least 20 km in length, IMT significantly improved exercise performance (20, 34).  Therefore, the 
purpose of this study was to determine if 6 weeks of IMT improved the performance of highly 
trained cyclists during a 20 km time trial in hypoxia.  We hypothesized that performing IMT for 
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6 weeks will significantly improve time trial performance in a hypoxic environment for highly 
trained cyclists compared to a sham training group. 
 
Statement of the Problem  
During exercise in hypoxia the body increases ventilation in response to a decrease in 
arterial oxygenation.  An increase in ventilation raises the work of breathing an additional 20 to 
30 percent greater than it is in normoxia.  IMT has been shown to attenuate the effects of the 
metaboreflex response, train the respiratory muscles, decrease work of breathing and 
significantly enhance performance in normoxia.  However, it is unclear if IMT can augment 
performance in a hypoxic environment, where ventilatory output is greater at any given 
workload.  
Purpose of the Study 
 The purpose of this study was to determine if 6 weeks of inspiratory muscle training 
improved trained cyclists’ 20 km time trial performance at a simulated altitude of 2500 m (8000 
ft). 
 
Delimitations 
1. Healthy trained male endurance cyclists (V̇O2max > 55 ml * kg-1 * min-1) were recruited 
for this study. 
2. Subjects were recruited from Indiana University via flyers, emails and contact with Little 
500 teams. 
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3. Data collection occurred in a laboratory setting where temperature, humidity and 
barometric pressure are relatively static. 
4. Performance was a fixed 20 km distance cycle time trial. 
5. A familiarization was performed to allow the subjects to get accustomed to the 
equipment, procedure and breathing hypoxic gas. 
6. Subjects were asked to wear their preferred cycling clothing and continued to wear the 
same clothing for each day of testing. 
7. Subjects were told they could bring their own cycling shoes and clips and continued to 
use the same ones for the duration of the study. 
8. Subjects were asked to complete a training log citing intensity and duration of each 
training session. 
9. Subjects trained the inspiratory muscles for 6 weeks between the pre- and post- time trial. 
10. Inspiratory muscle training was considered successful if the subjects saw an increase in 
their MIP as a surrogate marker for respiratory muscle strength. 
11. The adaptations to inspiratory muscle training were considered successful if the subjects 
experienced a significant improvement in their 20 km time trial performance in hypoxia. 
12. Subjects reported to the laboratory hydrated and 3 hours post-prandial and at least 24 
hours after any strenuous exercise. 
13. The subjects did not consume alcohol within 24 hours prior to exercise and did not 
consume caffeine within 6 hours prior to exercise. 
14. The subjects performed the testing at the same time of day. 
Limitations 
1. Subjects were selectively chosen to be highly trained cyclists. 
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2. Only male subjects were used for the experiment. 
3. Subjects were asked to report to the laboratory 3 hours post-prandial, but there was no 
way to know if they followed those directions. 
4. Subjects were asked to refrain from strenuous exercise at least 24 hours prior to entering 
the laboratory, but there was no way to tell if they followed that direction. 
5. Subjects were asked to keep a training log, but there was no way to know if that is 
accurate. 
6. Subjects filled out a questionnaire about previous injury and about training hours per 
week, but there was no way to know if they were being honest. 
7. Subjects were asked to perform to the best of their abilities for every test, but there was 
no way to tell if they were trying their hardest the whole time. 
8. Athletes were asked to breathe through a mask while completing the time trial in the 
laboratory which feels different than breathing without the mask. 
9. The findings in this study can only be attributed to the simulated altitude that the test 
takes place. 
10. We assumed that simulated altitude through breathing hypoxic gas elicits similar effects 
to actual altitude. 
11. Subjects were taught how to properly use the inspiratory muscle trainers, but there was 
no way to tell if they used them correctly. 
12. There was no way of knowing if subjects consumed alcohol within 24 hours of testing or 
if they consumed caffeine within 6 hours of testing. 
Assumptions 
1. Subjects accurately represented highly trained cyclists. 
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2. Subjects followed the guidelines that we provided them for training. 
3. The equipment used in the laboratory was reliable. 
4. The subjects arrived to the laboratory hydrated, 3 hours post-prandial and have not 
consumed alcohol or caffeine 24 and 6 hours prior to exercise, respectively. 
5. The values received for each test accurately represented the subject’s best effort. 
6. Motivation to exercise did not change between trials. 
7. The familiarization test eliminated the learning curve prior to actual testing. 
8. The apparatus used to measure metabolics did not alter the way the subject breathed. 
9. Simulated altitude correlated with actual altitude. 
10. Subjects are used to performing time trials. 
Hypotheses 
The study tested the following hypotheses: 
1. Inspiratory muscle training will improve highly trained cyclist’s 20k time trial 
performance in hypoxia. 
2. Inspiratory muscle training will increase the strength of the inspiratory muscles measured 
through MIP. 
3. Inspiratory muscle training will increase ventilation, breathing frequency and oxygen 
uptake during the 20k time trial in hypoxia. 
4. Inspiratory muscle training will have no effect on lung diffusion capacity. 
5. Inspiratory muscle training will have no effect on residual volume or any other static lung 
volumes. 
6. Inspiratory muscle training will decrease dyspnea during the time trial. 
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7. Inspiratory muscle training will have no effect on RPE during the time trial. 
Definition of Terms 
 Arterial blood oxyhemoglobin saturation (SpO2) – The percent of hemoglobin that is 
saturated with oxygen (Turner, 2013). 
 Diffusing Capacity of the Lung (DLCO) – the diffusing capacity of the lung is 
measured with carbon monoxide (CO) because CO is limited solely by diffusion.  It therefore is 
the best choice to determine the diffusing capacity of the lung. 
 Dyspnea – the clinical term for shortness of breath.  It is another way to perceive 
exercise (Eakin, 1995). 
Fixed Distance Time Trial (TT) – a set distance that the subjects ride as quickly as 
possible while control their speed.  This experiment with have a 20 kilometer TT. 
Frequency of Breathing (fB) – the number of breaths taken per unit time. 
 Forced Expiratory Volume of One Second (FEV1) – The volume of gas that can be 
exhaled over 1 second from a full inspiration (West, 2012). 
 Forced Expiratory Flow 25 to 75% (FEF25-75) – the average flow rate measured during 
the middle 25-75% of expiration (West, 2012). 
 Fraction of Inspired Oxygen (FiO2) – The percent of oxygen in a given environment. 
 Heart Rate (HR) – the amount of times your heart beats per unit time. 
 Hypoxia – an environment with a fraction of oxygen less than .2093.  
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 Maximal Flow Volume Loops (MFVL) – The maximum amount of pressure than can 
be produced through expiration and inspiration (West, 2012) 
 Maximal Expiratory Pressure (MEP) – The maximal amount of pressure that can be 
produced during expiration when starting the expiration from total lung capacity (West, 2012). 
Maximal Inspiratory Pressure (MIP) – The maximal amount of pressure that can be 
produced during an inspiration when starting from your residual volume (West, 2012). 
Maximal Oxygen Consumption (V̇O2max) – maximal volume (L) of oxygen that the 
body can consume in one minute. 
 Maximum voluntary Ventilation (MVV) – the maximum volume of air that can be 
inspired and expired in 6 seconds (Downey, 2006).  
 Normoxia – an environment with a fractional oxygen content of .2093. 
 Oxygen Consumption (V̇O2) – the amount of oxygen that the body consumes measured 
in liters of oxygen per minute. 
 Rated Perceived Exhaustion (RPE) – a scale that rates from 1 to 20 with 1 being the 
easiest and 20 your exercise limit that is used to measure exertion in subjects.  The subject 
indicates, by pointing to a number, how exhausting the current exercise is (Borg, 1982). 
 Residual Volume (RV) – the volume of gas remaining in the lung following maximal 
expiration (West, 2012). 
 Respiratory Exchange Ratio (RER) – the ratio between dietary fat and dietary 
carbohydrates being utilized during exercise (Goedecke, 2000). 
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 Time to Exhaustion Test (TTE) – a fixed workload test where the subjects attempt to 
maintain a fixed workload for as long as they can.  When they can no longer continue at the 
necessary workload the test is over. 
 Volume of Carbon Dioxide Expired (V̇CO2) – this is the volume of carbon dioxide that 
is produced by the body and expired through ventilation in liters per minute (West, 2012).  
 Ventilation (V̇V̇E) – the volume of air that is exhaled and inhaled.  It is measured in 
volume per unit time (West, 2012).  
 
 
 
 
 
 
 
 
 
  
15 
 
Chapter II: Literature Review 
 
Work of Breathing 
 Work of breathing is the oxygen demand of the respiratory muscles.  Until about 25 years 
ago it was believed that the work of breathing stayed relatively constant and it did not have an 
effect on exercise.  The respiratory muscles were thought to be non-fatiguing muscles, similar to 
cardiac muscles.  In 1992, Aaron et al. (1) performed a study that indicated that in a normoxic 
environment the inspiratory muscles consume up to 10 to 15 percent of total body oxygen.  Their 
data indicated that oxygen demand increased proportionally to the increase in ventilation and 
work throughout exercise (1).  It was still believed that the inspiratory muscles did not fatigue so 
that increase in work of breathing would not hinder the duration of exercise. 
Metaboreflex 
 As cardiac output increases during exercise the blood flow distribution is not equal 
throughout the body.  Blood is shunted away from areas that are deemed less important or non-
vital is shunted to areas that are of greater need.  There seems to be a hierarchy within the body 
for blood supply which starts with the brain at the top and moves down to other organs and 
muscles that the body which are vital for survival.   
Harms et al. (15) performed a study examining blood flow distribution during high 
intensity cycling with ventilatory assistance, ventilatory resistance or normal breathing.  The 
purpose of the study was to determine how ventilatory assistance and resistance affect work of 
breathing (WB) and if changing work of breathing has an effect on blood flow distribution.  
During the study the subjects cycled at a constant power output.  The WB decreased by 36.7 ± 
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26.6% with ventilatory assistance compared to the control and increased by 128.1 ± 25.2% 
during ventilatory resistance compared to the control.  As WB increased, the body prioritized the 
oxygen demand of the respiratory muscles over the leg muscles, by shunting blood away from 
the leg muscles and to the respiratory muscles through an increase in leg vascular resistance 
which decreased the percentage of total V̇O2 that was taken up by the leg muscles (15).  
  
Figure 1: WB compared to total body V̇O2 and V̇O2 of the legs (15) 
 
Figure 2: Working of breathing compared to Leg Vascular Resistance (15) 
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 During ventilatory assistance the subjects experienced a decrease in total body V̇O2, 
compared to the control, even though they were still cycling at the same workload (15).  This 
research indicates that these changes in V̇O2 are directly related to the change in WB.  The power 
output of the legs for the ventilatory resistance group did not change throughout the study, but 
they increased their total body V̇O2 and decreased V̇O2legs as a percentage of total body V̇O2.  
This indicated that the increased V̇O2 was a result of the increase in WB and the excess oxygen 
was consumed by the respiratory muscles.  Through sympathetic neural drive the body was able 
to prioritize the respiratory muscles over the working muscles by shunting blood away from the 
legs and to the respiratory muscles (15). 
This decline in percentage of total body V̇O2 to the working muscles during exercise 
could be detrimental to exercise.  In 2000, Harms et al. (13) performed another study on a time to 
either respiratory unloading, loading or normal breathing during a TTE test.  Performing a TTE 
with respiratory muscle unloading significantly increased cycling duration compared to the 
control and the ventilatory loading subjects.  They experienced a decline in V̇O2, breathing 
frequency, RPE and dyspnea when compared to the ventilatory resistance group.  They increased 
their ventilation and tidal volume compared to the ventilatory loaded subjects.  All of these 
adaptations are beneficial to exercise, but the problem is that during competition you are unable 
to compete while using ventilatory assistance.  They did not examine V̇O2leg, but based on the 
previous research (15) the changes in V̇O2 were related to the changes in WB during exercise and 
the differences in TTE were caused by the differences in WB between the groups.  There was an 
inverse relationship between WB and blood flow to the working muscles to the point where the 
working muscles could no longer be supplied with an adequate supply of oxygen for the given 
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workload.  If there was a way to decrease work of breathing through training it would be 
beneficial to exercise (6). 
Inspiratory Muscle Training 
 Inspiratory muscle training (IMT) was originally used in the medical field for patients 
suffering from COPD, heart failure and other various lung problems (6).  The objective was to 
strengthen their inspiratory muscles and decrease the rate of fatigue.  The gains from IMT 
increased linearly until about weeks 4-6 when the inspiratory muscle strength plateaus (8, 20, 26, 
34, 44).   
There are different ways to perform IMT and not all of them have produced beneficial 
results.  One type of IMT is voluntary isocapnic hyperpnea (VIH) where a subject enters the 
laboratory 3-5 times per week and breathes for up to 30 minutes at 60-90% of their maximum 
voluntary ventilation (MVV) (27).  During the 30 minutes of ventilation subjects are seated in an 
upright position allowing the body to rest while the ventilatory muscles mimic high intensity 
exercise allowing the researchers to isolate only the inspiratory muscles during high intensity 
exercise.  VIH has been shown to increase TTE tests, maximum sustainable ventilatory capacity, 
vital capacity and MVV, but it does not significantly increase maximal respiratory pressure.  The 
down side with VIH is that it is time consuming and difficult to perform because the subject has 
to come into the laboratory for every training bout (27). 
 Inspiratory pressure threshold loading (IPTL) is the most common type of IMT used in 
research (27).  During IPTL an individual is required to produce enough negative force to 
overcome a threshold load to initiate inspiration.  The subjects are required to exhale to residual 
volume (RV), place their mouth around the training device and inspire maximally against the 
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pressure resistance to total lung capacity (TLC) in order to complete one repetition.  The training 
protocol is to perform 30-40 repetitions of this maneuver twice a day for 5-7 days a week.  In 
about six weeks of training it has been shown to increase a subject’s maximal velocity, maximal 
rate of shortening, maximal power output, the endurance of their inspiratory muscles and cause 
diaphragm hypertrophy.  The protocol is convenient for subjects to perform because the training 
can be performed away from the laboratory and without experimenter supervision (8, 27).  IPTL 
has had mixed results during TTE studies, but has had better results during fixed distance time 
trial studies (20, 34, 35, 38, 41).   
 Inspiratory flow resistive loading (IFRL) requires individuals to inspire through a 2 mm 
diameter orifice which provides the resistive load(27).  The Test of Incremental Respiratory 
Endurance (TIRE) technique is used to train the subjects.  The TIRE technique uses a 2 mm 
diameter orifice to produce the resistive load and software that is run through a computer that 
attaches to an electronic manometer in the device.  The subjects are required to perform the 
training protocol, in which they perform several maximal inspiratory efforts to create a baseline 
value, then they must inspire 80% of the maximal effort and volume which is called the SMIP 
and the subject has to achieve this mark 6 times with a break between each effort (29).  
Completing 6 maximal efforts is considered finishing a stage of training.  Once they finish the 
first stage they receive 1 minute of rest followed by 6 more maximal efforts against 80% 
resistance.  Each time they complete a stage their recovery time decreases by 15 seconds.  If they 
cannot complete a stage then their training bout is complete.  Performing the TIRE technique 3 
times a week has been shown to increase their inspiratory muscle strength from 18 to 54% and 
have a small, but statically significant increase in their total lung capacity (27, 29, 40).   
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Using the TIRE protocol allows subjects to increase the difficulty of their training as their 
inspiratory muscle strength increases without coming into the laboratory and having the 
researcher increase the resistance.  During IPTL subjects are either unable to increase the 
resistance or are required to enter the lab periodically to have the resistance adjusted.   
IMT on Metaboreflex 
 Inspiratory muscle training is designed to decrease the WB which attenuates the 
metaboreflex response of the inspiratory muscles resulting in increased blood flow to the 
working muscles allowing the athlete to continue exercising at the same intensity.  Until recently, 
the research was only able to indicate that IMT attenuated muscle fatigue during exercise (8, 11, 
14, 34).   
 The body responds to exercise by increasing heart rate and mean arterial pressures.  
These are controlled by the sympathetic nervous system and are used to regulate blood flow to 
the specific areas of the body.  After 5 weeks of IMT subjects experienced an attenuated 
response from their heart rate and mean arterial pressure as compared to their pre-test and the 
control group during a eucapnic resistive breathing task (44).   
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Figure 3: Indicates the attenuation of MAP and HR during exercise for subjects who performed IMT 
compared to the Sham group(44) 
A decrease in mean arterial pressure and heart rate during a eucapnic resistive breathing 
task indicates that the WB of the inspiratory muscles decreased allowing the inspiratory muscles 
to generate the same amount of work with less blood flow (44).  This would be advantageous to 
athletes performing high intensity or long duration aerobic exercise where the working muscles 
have an increased oxygen demand.  This will allow the body to supply the working muscles with 
a greater quantity of oxygen compared to individuals who have a greater WB and should increase 
performance. 
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IMT and Performance 
 Inspiratory muscle training has been shown to improve performance during cycling and 
running time trials (km) (10, 20, 22, 34, 38), but has shown mixed results for TTE tests (8, 42).  
After IMT the subjects experienced an attenuated decline in MIP after testing, indicating a 
decrease in inspiratory muscle fatigue (8) and decreased WB throughout exercise allowing the 
sympathetic nervous system to lessen the metaboreflex of the inspiratory muscles.   
In a study performed by Romer et al. (34) subjects performed 6 weeks of IMT and 
experienced an increased MIP, maximal inspiratory flow, maximal inspiratory muscle power, 
optimal pressure and increased maximal rate of pressure development.  They also experienced a 
decrease rate of perceived exhaustion in the respiratory and peripheral muscles (RPE).  These 
physiological and psychological improvements led to a statistically significant improvement in 
time trial performance of 65 ± 30 seconds and 114 ± 38 seconds for a 20 and 40 km time trial, 
respectively, when compared to the pre-test.  This represented a 3.8 ± 1.7% and 4.6 ± 1.9% 
improvement during a 20 and 40 km time trial, respectively (34).  The majority of the time 
improvement occurred during the second half of each time trial.  Indicating that as the trial 
progressed that the expected increase in WB was attenuated by the IMT.  Based on these results, 
IMT attenuates the rate of inspiratory muscle fatigue during endurance exercise which agrees 
with the results from Witt et al. (44) that had a significantly lower mean arterial pressure post-
IMT compared to pre-IMT. 
Performance Testing 
 Time trial and time to exhaustion tests are both considered performance tests, but they do 
not have the same level of reliability (18, 28).  Originally, it was thought that having a subject 
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exercise at a fixed submaximal workload until exhaustion was the best way to determine 
performance, but now we know that this is not true.  A time to exhaustion test has a significantly 
greater variance (26.6%) than a fixed distance time trial (3.35%) (18).  This variance could be 
caused by a multitude of reasons, but one of the most likely reasons is motivation (43).  A time 
to exhaustion test is grueling because the subject has to be able to continue until they physically 
cannot go any farther which brings motivation, mood and experience into play.  Some subjects 
will not want to force their body to go through the necessary pain or they may think that they 
have reached their limit when, in fact, they have not.  If the subjects are not properly familiarized 
with a time to exhaustion test then they will experience a learning curve (28).  This creates a 
learning effect where it is necessary to do multiple familiarization trials prior to testing.  This 
creates a greater variance between tests compared to a fixed distance time trial. 
A study performed by McLellan et al., (28) had their subjects perform 5 TTE tests to 
analyze the variance from test to test.  The subjects performed significantly better during trial 3 
than trial 1 and 5 indicating that there was a learning curve between trial 1 and 3, but the 
difference between trial 3 and 5 was most likely due to motivation.  Trial 4 was not statistically 
significant from trials 3 or 5, but it did fall between the two indicating that the subjects’ 
motivation was decreasing after they reached, what they believed to be, their peak performance.  
There was also no statistical difference between trial 1 and 5 indicating that the subjects 
regressed back to their pre-learning ability (28).  With this variance throughout five tests it would 
be difficult to know if you were getting accurate results.   
Time trial tests have shown to have high reliability and validity due to the subject 
knowing that there is a set end point (18).  The subject is allowed to control the velocity at which 
they ride throughout the time trial allowing them to be more applicable for competition than TTE 
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tests.  During TTE tests subjects maintain a fixed velocity throughout the duration of the test, but 
during competitions cyclists’ velocity varies due to pacing strategies (39).  During competitions 
athletes pace themselves by fluctuating their power output throughout the race allowing them to 
complete the race with an increase in power known as an end spurt.  During a time trial subjects 
are able to fluctuate their power output to mimic the pacing strategy that would be used during 
competition (9).  Unlike a TTE test subjects only need to perform one familiarization test to 
control for the learning effect (18). 
Work of Breathing in Hypoxia 
 The body attempts to offset the decreased amount of oxygen that is consumed by each 
breath in hypoxic environments by increasing the rate of ventilation.  A reduction in arterial 
oxygen saturation triggers chemoreceptors in the body to stimulate increased ventilation.  It was 
originally believed that because of the drop in air pressure in hypobaric hypoxia subjects would 
experience a decrease in WB, but research now indicates that WB is greater in hypobaric hypoxia 
than in normoxia (7).  There are a few different reasons as to why this occurs.  During exercise in 
hypoxia the diaphragm has to increase its work output compared to normoxia.  The diaphragm 
produces 20-30% more work during exercise in hypoxia than normoxia because of the increase 
in breathing frequency and an increase in inspiratory resistive flow rate of 13% during 
submaximal exercise.  At maximal exercise subjects experienced similar levels of minute 
ventilation and ventilatory work.  The WB is also increased through greater percentages of flow 
limitation being reached in hypoxia which has been associated with increased oxygen demand of 
the inspiratory muscles (1, 2). 
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In hypoxia the arterial oxygenation in the body is reduced compared to normoxia causing 
a reduction in the quantity of oxygen sent to the inspiratory muscles which increases the rate of 
fatigue and leads to an increased WB.  In response to the drop in arterial oxygen saturation the 
diaphragm increases vasodilation of its arteries.  In ponies it has been shown that during maximal 
exercise in hypoxia the oxygen demand of the diaphragm was the same or slightly less than the 
oxygen supply sent to the working muscles (25).  It is still unknown if these same adaptions 
occur in humans during intense exercise, but, during rest and submaximal exercise, hypoxia 
stimulates vasodilation.  In hypoxia the inspiratory muscles increase their use of their glycogen 
stores and increase lactate production compared to normoxia which indicates a greater usage of 
anaerobic pathways during exercise leading to an increased rate of fatigue (2).   
A study performed by Loeppky et al. (23) had subjects stay in an environmental chamber 
for 10 hours on three separate occasions and environments, hypobaric hypoxic, normobaric 
hypoxic and normoxic hypobaria.  During the first hour in the chamber the ventilatory response 
for the participants was not significantly different between normobaric hypoxia and hypobaric 
hypoxia, but as the testing continued the ventilation was significantly greater at 3, 6 and 9 hours 
in normobaric hypoxia compared to hypobaric hypoxia.  This significant increase in ventilation 
at 3, 6 and 9 hours will not affect this study because the 20 km time trial will take highly trained 
athletes less than an hour to complete.  The subjects will have a similar ventilatory response to 
hypobaric hypoxia while they exercise in normobaric hypoxia (23). 
IMT and Hypoxia 
 Currently, there is a dearth of research on IMT and hypoxia.  The small sample of 
research indicates that IMT is beneficial for athletes competing in hypoxia.  IMT has been shown 
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to attenuate the decline that occurs in arterial saturation as hypoxia increases (24).  Subjects 
performed 4 weeks of IMT prior to having their resting arterial saturation taken at sea level, 1400 
m, 4880 m and 5550 m.  There was a significant difference between the IMT and control groups 
for resting arterial saturation at 4880 and 5550 m, but not at 1440 m or at sea level (24).  This 
indicates that there must be a critical point where IMT is able to attenuate the effects of hypoxia 
on arterial saturation at rest, but this critical point seems to be at a greater elevation for rest than 
it is for exercise. 
 A study performed by Downey et al., (8) examined the effects of IMT on a treadmill time 
to exhaustion test at a simulated altitude of 3000 m (14% O2).  There was no difference in resting 
arterial saturation between the two groups which indicates that the critical point is at an altitude 
of greater than 3000 m, but that was not the main objective of this study.  They examined the 
effect of IMT on performance in hypoxia by using a treadmill time to exhaustion test set at 85% 
of their V̇O2max in normoxia.  They also examined the effect of IMT on a multitude of 
physiological variables.  Inspiratory muscle training caused significant hypertrophy in the 
diaphragm which resulted in an increase in MIP and end-inspiratory pressure.  During the 
treadmill test to exhaustion the IMT group experienced a significant decrease in inspiratory 
muscle fatigue during exercise in both normoxia and hypoxia as measured by performing a 
maximal voluntary ventilation test pre- and post-testing.   
 During the TTE test IMT group experienced a significantly lower V̇O2 (8-12%), 
ventilation (25 ± 3%) and cardiac output (14 ± 2%) and a significantly greater arterial saturation 
(4 ± 1) and increased lung diffusing capacity (22 ± 3%).  They also reported a lower RPE and 
dyspnea rating post IMT compared to the control.  Based on these results one would expect there 
to be an improvement in TTE performance, but there was no statistical difference between the 
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two groups.  The decrease in V̇O2, ventilation and cardiac output indicate that there was 
decreased blood flow to the inspiratory muscles since the subjects were able to perform the same 
workload.  The TTE test on the treadmill was set at 85% of their V̇O2max, which was measured in 
normoxia making the workload even closer to V̇O2max in hypoxia.  The test in normoxia lasted 
22.0 ± 1.7 minutes (control) and 18.1 ± 1.9 minutes (IMT) which were not significantly different 
from each other or from their pre-test.  There was no change in performance possibly because 
they used TTE, which has low reliability and validity and mixed results with IMT.  It could also 
have not been significant because the test duration was not long enough to see improvement (8).  
There have also been mixed results with IMT and running, especially in TTE tests. 
  
Figure 4: Shows that subjects who perform IMT  Figure 5: Shows the increase in SaO2 from pre- to post-IMT  
decrease their ventilation and V̇O2 are decreased 
 
 During the TTE in hypoxia the tests lasted 9.7 ± 1.5 min and 7.4 ± 1.2 min for the control 
and IMT, respectively.  There was no statistically significant difference between or within the 
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groups for duration.  The duration of this test was less than half the duration of the TTE in 
normoxia.  Once again the reason for this not being significantly different could be because the 
duration was too short, they used a TTE test instead of a TT and the subjects performed the test 
while running instead of cycling.  It is most likely a combination of the three that limited the 
effect of the IMT on the TTE.  Based on these results and physiological adaptations that IMT 
causes we believe that performance should improve (8).  That is why during this study we will be 
using a 20km TT instead of TTE and cycling instead of running.  We expect to see the same 
physiological adaptions, but also see an increase in TT performance. 
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Chapter III: Methods 
 The purpose of this study was to determine if 6 weeks of inspiratory muscle training 
improves trained cyclists’ 20 km time trial performance at a simulated altitude of 2500 m (8000 
ft). 
Subjects 
 Thirty one male subjects between the ages of 18 and 25 were recruited for this study.  
Potential subjects were recruited through email or phone calls directly to them or their coach, as 
well as flyers placed around Bloomington, IN.  The subjects were healthy non-smokers with no 
history of lower limb injury in the past year.  They all obtained a maximal oxygen consumption 
(V̇O2max) of greater than 55 ml * min-1 * kg-1 and were participating in a training regimen to 
qualify for the study.  They were tested at the Indiana University Human Performance 
Laboratories and were approved by Institutional Review Board for the protection of human 
subjects.  All subjects filled out a medical questionnaire and completed an Indiana University 
Internal Review Board approved informed consent before any exercise testing was performed. 
Study Design 
 Subjects appeared in the laboratory on four separate occasions.  Each occasion the subject 
arrived at least 3 hours post-prandial, 24 hours post-alcohol consumption, 6 hours post-caffeine 
consumption and was well hydrated.  The initial visit was used to identify which subjects 
qualified for the study.  Immediately upon entering the Indiana University Human Performance 
laboratory the subjects filed out a medical questionnaire and an informed consent form.  After 
the subjects passed that portion of the qualification, they performed an incremental V̇O2max 
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test(3) and were not allowed to continue in the study if they did not achieve a V̇O2max of at least 
55 ml * min-1 * kg-1.   
 The second visit was at least 48 hours after the first visit and was used as a 
familiarization visit to prevent a learning effect.  The subjects arrived to the laboratory as if it 
were a real test day.  They arrived in their cycling gear and were encouraged to bring their own 
toe clips for the cycle ergometer (Velotron, RacerMate Inc., Seattle, WA).  They continued to 
wear these same clothes and bring the same toe clips for the duration of the study.  Upon 
entering the laboratory their height and weight were taken and then they proceeded to perform a 
familiarization for maximal flow volume loops (MFVL), static lung volumes (residual volume), 
lung diffusing capacity (DLCO), maximal inspiratory pressure (MIP) and maximal expiratory 
pressure (MEP).  Following the lung function tests the subjects performed a 20k time trial on a 
Velotron while breathing hypoxic gas (FIO2 = 16.1%).  Immediately upon completion of the time 
trial, the subjects performed a MFVL and MIP test.  This same protocol was followed for day 3 
and day 4 of testing, separated by a six week IMT or sham training period.  Days 1, 2, and 3 of 
testing were separated by at least 48 hours. 
Inspiratory Muscle Training 
 Subjects were pair matched based on pre-exercise values of MIP and randomly placed 
into either the control (sham) or the IMT group.  They were blinded to which group they were 
placed in.  Subjects in each group were instructed on how to use their inspiratory muscle trainer 
(PrO2, PrO2 Health, Inc., Smithfield, Rhode Island) which uses flow resistive loading.  The 
device, which is a pressure manometer with a 2mm orifice which provides the resistance, is 
connected to an app on the subject’s phone or iPad through blue tooth.  The app is designed to 
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run the “Test of Incremental Respiratory Endurance” (TIRE) regimen (29).  To start the program 
the subjects perform several maximal inspirations where they initially exhale to RV and then 
inspire maximally to total lung capacity (TLC).  This is used as the baseline and recorded as their 
sustained maximum inspiratory pressure (SMIP).  The program requires them to reach 80 or 30% 
of their SMIP depending if they are in the IMT or Sham group, respectively.  Previous research 
has shown that having the subjects achieve 30% of their SMIP, while performing the TIRE 
protocol, does not elicit improvements in inspiratory muscle strength (29).  The TIRE protocol 
consists of 6 levels with each level being made up of 6 breathes with a varying amount of time 
between each breath.  The duration between each subsequent level decreases, but the percent of 
SMIP needed to continue remains the same. 
Level Recovery Time (seconds) 
A 40  
B 30  
C 20  
D 15 
E 10 
F 5 
 
They continue the protocol until they either complete all 6 levels or fail on a breath two times in 
a row (30).  This training is repeated three times per week for 6 weeks.  Compliance was 
monitored by experimenters throughout the 6 weeks by checking each subject’s results using 
their login information. 
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Measurements 
Pulmonary Function: 
 MFVLs were used to determine vital capacity (VC), 1-second forced expiratory volume 
(FEV1), and the mean forced expiratory flow between 25% and 75% of forced vital capacity 
(FEF25-75%) (31).  The subjects also underwent residual volume (RV), and DLCO tests which 
were performed using the metabolic cart (Vmax Encore Metabolic Cart, CareFusion Corporation, 
San Diego, CA) in the Indiana University Human Performance Laboratory.  These tests were 
performed following the guidelines provided by the 2005 update of the Standard of Spirometry 
by the American Thoracic Society (ATS) (31).  Each test was performed in triplicate unless the 
values were greater than a 10% difference in which case the test was performed until three trials 
were within the acceptable range of 10 percent.  The average of the values was recorded.  The 
order by which the tests were performed was: 
1. Maximal flow volume loops 
2. Static lung volumes (5 minutes between each test) 
3. DLCO (5 minutes between each test) 
4. MIP 
5. MEP  
Maximal Inspiratory and Expiratory Pressure 
 The subject’s MIP was determined by having a small leak within the closed mouth-piece 
(#2700 and #9060, Hans Rudolph, Shawnee, KS) system that allowed a maximum flow of 50 ml 
* s-1 to prevent glottis closure during the maneuvers.  The mouth piece was connected, via a side 
port, to the metabolic cart which was calibrated regularly using a three liter syringe.  Subjects 
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performed a MIP by exhaling to RV, then maximally inhaling to their TLC.  They repeated this 
test until three of the trials were within 10 percent and the average of the trials was recorded.   
 The MEP was performed using the same equipment.  The only difference was that the 
subjects began the test at TLC and forcefully exhaled to RV.  This test was repeated until three 
of the trials were within 10 percent and the average of the trails.                                                                                                                                                                                                                                                                                
was recorded. 
Arterial Oxygen Saturation (SaO2) Measurement: 
 Arterial oxygen saturation was measured indirectly through pulse oximetry.  The pulse 
oximeter (Nellcor N-395 Pulse Oximeter, Medtronic, Minneapolis, MN) was calibrated 
periodically following the directions in the manufacturer’s manual.  The forehead sensor was 
replaced was necessary.  
Progressive Maximal Exercise Test: 
 V̇O2max was determined through a progressive cycle ergometer test and was performed in 
normoxia.  The subjects performed the V̇O2max test on a computer controlled electronically 
braked cycle ergometer (Dynafit Pro, RacerMate Inc., Seattle, WA).  The subjects were allowed 
to warm up for five minutes at 100 watts (W) on the Velotron cycle ergometer.  They were 
encouraged to cycle around 90RPMs for the V̇O2max.  After the warm-up the subjects rested for 
five minutes on the Velotron.  After the rest period the test began.  The Velotron was loaded with 
100 Watts of resistance and increased by 25W each minute until the subject could not maintain 
the desired workload (Weavil, 2012).  V̇O2max was considered achieved if two of the following 
criteria were achieved: 
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1. Heart rate > 90% of age predicted max 
2. Respiratory equivalent ratio (RER) > 1.10 
3. A plateau (<150 ml change) in V̇O2 with an increase in workload 
 
Hypoxic Inspirate Delivery System: 
During the time trial, subjects breathed from two balloon reservoirs (approximately 850L 
each) with hypoxic gas produced from a nitrogen generator (CAT-12 model, Colorado Altitude 
Training, Boulder, CO).  The generator pumped air with an FIO2 of 16.1% which with a typical 
barometric pressure in Bloomington, IN gives an inspired PO2 of 120 mmHg which is equivalent 
to an altitude of 2500 m / 8000 ft.  While in the balloon, the mixed gas has approximately the 
same humidity and temperature as room air and care was take to prevent any leaks in the system.  
Two, two way valves were used to allow the rider to breathe from one bag at a time.  This made 
it possible to refill one of the bags while the subject breathed off of the other bag. 
20 km Time Trial: 
 The subjects arrived at the laboratory at the same time of day for each time trial.  They 
arrived 3 hours post-prandial, at least 24 hours post-alcohol consumption, at least 6 hours post-
caffeine consumption and were adequately hydrated.  They were unable to consume water during 
the time trial due to the equipment that was worn.  A familiarization and two experimental 20 
kilometer (km) time trials were performed by each subject.  The objective of the familiarization 
was to decrease the impact of the novelty of a 20km time trial while breathing hypoxic gas.   
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 Prior to the performing the 20km time trial the subjects were able to adjust their saddle 
and toe clips; they were allowed to bring their own toe clips and saddle.  Prior to exercise, the 
Velotron was set so that 90 RPMs was equivalent to the wattage the subject produced at 70% of 
their V̇O2max.  The subject sat on the bike at rest, while breathing hypoxic gas, for 3 minutes prior 
to exercise while metabolics were recorded.  The subjects were allowed to warm up for 5 
minutes at 100W followed by 5 minutes of rest.  The investigator counted down from 3 and 
began the time trial (CompuTrainer, RacerMate Inc., Seattle, WA).  During the time trial the 
subjects were able to control the resistance of the Velotron to mimic gearing up or down during 
competition.  The subjects were allowed to know the distance traveled, but everything else was 
hidden.  Every 4km their rate of perceived exertion (RPE) and dyspnea were collected using the 
Borg’s and a modified Borg’s scale, respectively.  Metabolics were collected every 4km.  IC 
maneuvers were also completed every 4km for the determination of inspiratory flow limitation.  
Average power output was analyzed every 4km using WKO+ software (Peaksware LLC, 
Lafayette, Colorado).  The test was completed once the subject reached 20km, and completion 
time was recorded to the tenth of a second.  The post-exercise measures of MIP and MVFL were 
performed beginning within 60s after the completion of the exercise bout and were completed for 
all subjects within 5 minutes of completed of the exercise bout.   
Ventilatory and Metabolic Measurements: 
 Ventilation and metabolics were measured continuously through a metabolic cart.  The 
program computed the ventilatory and metabolic data breath by breath which was used to 
determine the average of the last minute of each 4km segment.  The metabolic cart was 
calibrated by using a 3 L syringe to pull gas over the flow ports in the mouth piece within 
physiological norms.  Subjects wore a facemask (Hans Rudolph #7450V2, Kansas City, MO) 
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which was attached to a two-way non-rebreathing valve with flow sensors inside of the mouth 
piece that sent the breath by breath reading to the metabolic cart.  The metabolic cart took breath 
by breath measurements of fractional inspired and expired O2 and CO2.  Heart rate was measured 
continuously throughout the time trial using a Polar heart rate monitor and a 4km average was 
recorded. 
Flow-Volume Relationships: 
 Flow-volume loops were determined prior and post exercise.  Flow rates were measured 
using the metabolic cart and used to determine the subject’s MFVL, FEV1, FEV25-75% and VC.  
MFVLs were performed by having the subject inhale to TLC then forcefully exhale to RV and 
inhale to TLC.  Subjects were vigorously encouraged during the MFVL and these values were 
taken in triplicate pre- and post-exercise.   
Training Log 
 Subjects were required to keep a log of their workouts performed between their pre- and 
post-test.  They recorded their intensity, power output or distance (km), and duration, time, for 
each workout.  They were instructed not to increase their intensity and duration throughout the 
study.  They could fluctuate from day to day, but they could not continually increase their 
intensity and duration throughout the study.  This was closely monitored so that the differences 
from pre- and post-training were caused by the IMT and not training. 
Data Analysis 
 Data were analyzed using IBM SPSS version 22 statistical software.  A Shapiro-Wilk test 
was used to determine normality in all dependent variables.  To test the hypothesis that 6 weeks 
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of IMT will improve performance during a 20k time trial in hypoxia, a 2x2 split-plot repeated 
measures ANOVA was used with treatment group (IMT vs. SHAM) as a between subjects 
independent variable and time (Pre- vs. Post-treatment) as a within subjects independent 
variable.  A priori tests of simple main effects was used to determine significant differences in 
dependent measures, with a Bonferoni correction used to control Type 2 error rate with multiple 
comparisons.  For all comparisons, an alpha level of 0.05 (one-tailed) was used for significance.   
 .   
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Chapter IV: Results 
Table 1. Subject Characteristics prior to training 
 Control (n = 5) IMT (n = 8) 
Age (years) 21.0 ± 0.8 22.4 ± 0.9 
Height (cm) 175.9 ± 2.3 178.5 ± 3.1 
Mass (kg) 72.6 ± 1.3 75.4 ± 3.6 
Body Fat (%) 12.6 ± 1.4 12.7 ± 1.2 
TLC (L) (% predicted) 6.50 ± 0.42 (95%) 7.12 ± 0.48 (104%) 
RV (L) (% predicted) 1.47 ± 0.28 (87%) 1.25 ± 0.20 (74%) 
FVC (L) (% predicted) 5.17 ± 0.14 (102%) 5.97 ± 0.29 (117%) 
FEV1 (L) (% predicted) 4.34 ± 0.25 (105%) 4.70 ± 0.25 (114%) 
FEF25-75% (L/s) (% predicted) 4.78 ± 0.63 (116%) 4.35 ± 0.37 (106%) 
PEF (L/s) 10.86 ± 1.12 10.03 ± 0.62 
DLCO (ml/min/mmHg) 35.6 ± 1.6 38.3 ± 3.4 
MIP (cm H2O) 143.9 ± 7.8 127.6 ± 13.4 
MEP (cm H2O) 140.8 ± 16.4 151.9 ± 15.6 
V�O2max (L/min) 4.46 ± 0.19 4.74 ± 0.37 
V�O2max (ml/kg/min) 61.7 ± 2.0 63.5 ± 3.4 
Values are mean ± S.E. No signficant differences between groups (P ˃ 0.05); TLC: total lung 
capacity; RV: residual volume; FVC: functional vital capacity; FEV1: forced expiratory volume in 1 
second; FEF25-75%; forced expiratory flow during 25-75% of vital capacity; PEF: peak expiratory flow; 
DLCO: lung diffusing capacity; MIP: maximal inspiratory pressure; MEP: maximal expiratory 
pressure. 
 Subject characteristics are shown in table 1.  There were no significant differences 
between the sham and IMT group for age, height, mass and body fat percentage.  All resting 
pulmonary function measures were not significantly different between the sham and IMT group 
and fell within the normal limits for a healthy individual (32).  Maximal oxygen consumption, 
both absolute and relative, were not significantly different between the two groups.  Compliance 
with the IMT, which was performed 3 times a week for 6 weeks, was not significantly different 
between the groups (IMT = 86.5 ± 3.2%, Sham = 86.7 ± 4.5%). Subjects continued to train at a 
similar frequency and intensity during the training as they had in the weeks prior based on their 
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self-reported training log.  There were no significant changes in mass (pre-test 74.3 ± 2.2, post-
test 74.4 ± 1.7) or body fat percentage (pre-test 12.7 ± 0.9, post-test 13.1 ± 0.8) during the 6 
weeks of training.   
3.1 Inspiratory Muscle Strength 
 Table 2 shows MIP for each group before and after 6 weeks of training.  The IMT group 
significantly improved their MIP when compared to their pre-test and to the sham group.  This 
represents a significant increase in inspiratory muscle strength for the IMT group.  MIP in the 
sham group was not different between pre- and post-training. 
Table 2. Inspiratory Muscle Strength  
   Pre Post 
MIP (cmH2O) 
IMT (n = 8) 127.6 ± 13.4 159.0 ± 15.3*ꝉ 
Control (n = 5) 143.9 ± 7.8 150.9 ± 12.5 
Values are mean ± S.E.    
   * Significantly different from pre-training (p ≤ 0.05)   
    ꝉ Significantly different from control    
 
3.3 Metabolic, ventilatory and TT results 
The increase in inspiratory muscle strength did not have a significant effect on average 
power (figure 2), but average time (figure 1) to completion of the 20km TT is approaching 
significance (p = 0.06).  Table 3 shows each group’s average over each 4km segment during the 
time trial.  There were no significant differences in any measure between the groups.   
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Figure 1. Average time to complete the 20km time trial.  Values are mean + SE. * = significantly 
different from Pre (p < 0.05). 
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Figure 2. Average power during the 20km time trials. Values are means + SE.  * = significantly 
different from Pre (p < 0.05). 
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 Table 3. Time Trial Results           
  Pre-train      Post-train     
  4k 8k 12k 16k 20k  4k 8k 12k 16k 20k 
Control            
 V�O2 (L/min) 3.70 ± 0.23 3.66 ± 0.21 3.71 ± 0.24 3.87 ± 0.20 3.97 ± 0.27  3.52 ± 0.22 3.67 ± 0.11 3.68 ± 0.07 3.62 ± 0.15 4.04 ± 0.10 
 V�O2 (ml/kg/min) 50.9 ± 2.4 50.4 ± 2.7 51.2 ± 3.4 53.3 ± 2.8 54.7 ± 3.8  49.1 ± 2.9 51.1 ± 1.4 51.3 ± 1.1 50.5 ± 2.1 56.3 ± 1.2 
 V�E (L/min) 108.9 ± 13.2 105.5 ± 10.6 113.5 ± 12.1 123.3 ± 13.6 138.4 ± 15.6  104.8 ± 10.5 108.0 ± 5.5 110.4 ± 3.8 111.8 ± 8.9 143.5 ± 5.4 
 ʄR (breaths/min) 46.6 ± 4.7 47.2 ± 4.7 53.7 ± 5.1 57.7 ± 5.6 65.6 ± 5.7  46.5 ± 4.0 51.6 ± 3.4 54.0 ± 2.5 56.7 ± 4.0 66.6 ± 3.5 
 SaO2 (%) 89.0 ± 1.2 85.3 ± 3.3 88.0 ± 0.0 90.0 ± 1.0 87.5 ± 0.5  91.5 ± 0.3 90.5 ± 0.9 90.5 ± 0.6 90.3 ± 1.5 88.0 ± 1.1 
 HR (bpm) 153.4 ± 4.3 161.3 ± 6.9 165.6 ± 8.8 170.6 ± 8.0 176.4 ± 7.0  151.3 ± 2.0 163.0 ± 3.2 167.1 ± 4.4 167.6 ± 5.9 174.0 ± 4.0 
 Dypsnea (Borg 1-10) 4.4 ± 0.7 5.2 ± 0.8 6.2 ± 0.6 7.8 ± 0.4   4.6 ± 0.7 5.4 ± 0.5 6.6 ± 0.4 7.6 ± 0.2  
 RPE (Borg 6-20) 12.6 ± 0.8 12.2 ± 1.5 15.4 ± 0.8 16.4 ± 0.6   13.0 ± 0.7 14.0 ± 0.4 15.6 ± 0.6 16.2 ± 0.7  
 Power (Watts) 175.2 ± 11.1 181.4 ± 5.4 192.8 ± 8.1 196.4 ± 5.8 210.4 ± 7.3  186.6 ± 6.9 193.4 ± 1.7 188.0 ± 4.9 183.2 ± 7.7 * 200.4 ± 4.7 
 Duration (min) 7.65 ± 0.22 7.49 ± 0.10 7.32 ± 0.12 7.26 ± 0.08 7.08 ± 0.09  7.46 ± 0.11 7.30 ± 0.02 7.39 ± 0.09 7.49 ± 0.12 * 7.22 ± 0.06 
             
IMT            
 V�O2 (L/min) 3.43 ± 0.20 3.43 ± 0.22 3.43 ± 0.20 3.39 ± 0.21 3.47 ± 0.20  3.70 ± 0.22* 3.76 ± 0.25* 3.60 ± 0.25 3.59 ± 0.26 4.05 ± 0.24* 
 V�O2 (ml/kg/min) 45.8 ± 2.3 45.8 ± 2.3 46.8 ± 2.1 45.1 ± 2.2 46.6 ± 3.0  48.1 ± 1.9 47.7 ± 1.8 46.8 ± 2.5 46.5 ± 2.5 52.5 ± 2.2 
 V�E (L/min) 100.8 ± 8.0 99.3 ± 6.2 96.5 ± 4.5 95.6 ± 5.5 113.5 ± 6.7  113.4 ± 8.3* 109.8 ± 6.4* 106.2 ± 8.7 107.7 ± 10.3* 137.1 ± 9.7* 
 ʄR (breaths/min) 39.5 ± 3.8 40.6 ± 2.7 41.6 ± 3.0 41.1 ± 2.3 50.7 ± 2.7  44.9 ± 4.5* 46.1 ± 4.0* 44.1 ± 2.4 44.8 ± 2.0* 53.5 ± 2.7 
 SaO2 (%) 88.1 ± 1.3 86.6 ± 1.1 87.4 ± 1.8 87.2 ± 2.0 86.3 ± 2.2  88.1 ± 0.9 87.9 ± 1.0 87.9 ± 1.4 87.4 ± 1.1 87.3  ± 1.1 
 HR (bpm) 147.1 ± 4.4 154.8 ± 3.2 154.4 ± 4.0 155.1 ± 5.0 160.8 ± 6.4  151.1 ± 3.7 159.1 ± 4.4 161.3 ± 4.4* 161.8 ± 5.9* 166.9 ± 5.6* 
 Dypsnea (Borg 1-10) 4.1 ± 0.5 5.0 ± 0.6 5.3 ± 0.7 5.6 ± 0.8   4.4 ± 0.6 4.9 ± 0.6 5.8 ± 0.6 6.3 ± 0.7*  
 RPE (Borg 6-20) 13.5 ± 0.5 15.3 ± 0.5 15.6 ± 0.6 16.4 ± 0.7   13.6 ± 0.7 14.6 ± 0.6 15.9 ± 0.6 16.6 ± 0.6  
 Power (Watts) 213.9 ± 15.0 198.8 ± 15.8 192.0 ± 15.4 186.8 ± 19.0 209.7 ± 20.9  205.3 ± 19.3 202.9 ± 13.6 
197.0 ± 
16.3 193.6 ± 18.2* 211.8 ± 17.6 
 Duration (min) 7.16 ± 0.24 7.34 ± 0.27 7.44 ± 0.27 7.58 ± 0.36 7.28 ± 0.36  7.05 ± 0.15 7.23 ± 0.21 7.37 ± 0.28 7.45 ± 0.34 7.18 ± 0.29 
 Values are mean ± S.E.           
 * Significantly different from pre-training (p ≤ 0.05)         
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The absolute oxygen consumption at the 4km, 8km and 20km marks were significantly 
increased during the post-test compared to the pre-test for the IMT group (figure 3).  Ventilation 
was significantly increased in the IMT group after training during the 4, 8, 16, and 20km 
segments (figure 4).  Subjects in the IMT group also experienced an increase in their heart rate 
after IMT during the 12, 16 and 20km segments (figure 5).  Overall, absolute V̇O2, ventilation 
and fB were significantly increased (Table 4) after 6 weeks of IMT.   
Table 4. Metabolic and Heart Rate Averages    
  IMT SHAM 
 Pre Post Pre Post 
V�O2 (L/min) 3.41 ± 0.19 3.61 ± 0.21* 3.71 ± 0.18 3.64 ± 0.12 
V�O2 (ml/kg/min) 45.3 ± 2.0 46.9 ± 2.0 51.1 ± 2.3 50.7 ± 1.6 
Ventilation (L/min) 99.6 ± 5.5 110.4 ± 6.8* 113.6 ± 10.6 111.0 ± 5.5 
fB (Breaths/min) 41.4 ± 2.8 45.1 ± 2.9* 52.4 ± 4.8 54.3 ± 2.9 
Heart Rate (bpm) 151.8 ± 4.4 158.8 ± 4.5 165.4 ± 6.6 164.4 ± 3.3 
Values are mean ± S.E     
  * Significantly different from pre-test (p < 0.05)    
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Figure 3. Average V̇O2 (L/min) for each 4km segment.  Values are mean + SE.  * = significantly 
different from Pre (p < 0.05). 
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Figure 4. Average V̇E (L/min) for each 4km segment.  Values are mean + SE.  * = significantly 
different from Pre (p < 0.05). 
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Figure 5. Average HR (bpm) for each 4km segment.  Values are mean + SE.  * = significantly 
different from Pre (p < 0.05). 
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Figure 6. Duration (min) for each 4km segment.  Values are mean + SE.  * = significantly 
different from Pre (p < 0.05). 
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Figure 7. Power (watts) for each 4km segment.  Values are mean + SE.  * = significantly 
different from Pre (p < 0.05). 
As expected both groups experienced a decline in arterial oxygen saturation, but there 
was no significant difference between groups or within each group at any time point.  Inspiratory 
muscle training had no significant effect on RPE during the time trial.  Dyspnea was significantly 
decreased at the 16km mark in the IMT after training, but not significantly different throughout 
the test.   
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Chapter V: Discussion 
 The major findings of this study were that 6 weeks of inspiratory muscle training 
significantly improved endurance performance in hypoxia, and increased inspiratory muscle 
strength, ventilation , frequency of breathing , and V̇O2 during a 20km cycle ergometry time trial 
in hypoxia.  This was the first study, to our knowledge, to examine the effect of inspiratory 
muscle training on highly trained endurance athletes during a fixed distance time trial in hypoxia.  
Our results suggest that endurance athletes who are competing acutely at moderate altitude in an 
event lasting ~30-35 minutes would experience a significant improvement in performance by 
completing 6 weeks of IMT prior to altitude exposure.  
5.1 Time Trial Performance 
 To date, only one other published study has examined the effects of chronic IMT on 
exercise performance in hypoxia.  Downey et al. (8) performed a similar study using a fixed 
workload time to exhaustion test (TTE) in hypoxia and saw that IMT did not have an effect on 
duration.  The main difference between this study and ours was our use of a set distance time 
trial versus a fixed work load TTE trial in the work of Downey et al.  During the TTE trial in 
their study, test subjects experienced a significant decline in ventilation, V̇O2, dyspnea, RPE and 
an increase in SaO2 at the same workload post-IMT, but no change in TTE.  The Downey et al. 
paper concludes that after 6 weeks of IMT, running economy in hypoxia is improved, but 
performance effects are unclear.  We chose to re-examine the concept of IMT effects on hypoxic 
exercise performance by using a longer fixed distance TT in place of a shorter TTE trial because 
of the increased reliability (18, 28) and applicability to endurance performance (39).  A 20km TT 
in hypoxia took our subjects approximately 30-40 minutes, compared to the 7-10 minutes that 
most subjects ran in the TTE trial in Downey et al.  Additionally, we selected cycling as the 
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mode of exercise versus running, as used in Downey et al., because IMT has been shown to have 
more consistent, positive effects on cycling performance than running performance (20, 34, 42).  
In contrast to the work of Downey et al., we found that a 20km time trial performance in hypoxia 
was improved by 1.4% which is approaching significance (p = 0.06).  Our data indicate that IMT 
is a useful technique for improving endurance performance with acute exposure to hypoxia. 
 We hypothesized that there would be greater potential for IMT to affect endurance 
performance in hypoxia than normoxia, even though several independent studies have clearly 
documented the ergogenic effects of IMT on normoxic exercise performance.  Hypoxia 
significantly increases work of breathing by an additional 20 to 30 percent (2) during 
submaximal endurance exercise resulting in an augmentation in the metabolic demand of the 
respiratory muscles and an increase in dyspnea (36).  It has been shown that by unloading the 
respiratory muscles, in hypoxia, work of breathing is attenuated by 29% during 4 minutes of 
cycling at 160 watts (21).  Decreasing work of breathing attenuates the metabolic demand of the 
respiratory muscles (15).  With the cyclists increasing V̇E, V̇O2, and fb while dyspnea remained 
unchanged, it can reasonably be assumed that the cyclists improved their breathing tolerance 
after 6 weeks of IMT. 
The performance improvements in our study were not as great as the ones in normoxia 
where Romer et al. saw a 3.8 ± 1.7% and 4.6 ± 1.9% improvement in during 20km and 40km 
TT, respectively.  Subjects in our study experienced an improvement of 1.4 ± 1.9%.  According 
to Hopkins et al.(17), the smallest amount of variation that significantly enhances an athlete’s 
ability to win an event is about half the variation of the event (17).  There is no published 
research for the variation of a 20km TT in hypoxia, but a study performed by Paton et al. (33) 
determined that a TT with the duration of about an hour has a ~1% variation.  An improvement 
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of 0.5% would be considered sufficient to increase the athlete’s chances of winning.  Therefore, 
the translational application of this work is that after 6 weeks of IMT, an improvement of 1.4 ± 
1.9% would likely impact competitive performance in a competitive 20km cycling event at 
altitude.  
5.2 Inspiratory Muscle Strength 
 Following 6 weeks of training, the IMT group significantly improved their inspiratory 
muscle strength compared to the control group.  Our study used MIP as an indicator of 
inspiratory muscle strength (20, 35, 38).  There are two commonly performed methods of 
training the inspiratory muscles; inspiratory flow resistive loading (IFRL) and inspiratory 
pressure threshold loading (IPTL).  Both of these methods have been shown to improve MIP (27, 
35, 38, 40).  In our study, IFRL was performed by both groups with varying degrees of resistance 
between the groups.  Unlike IPTL, where subjects perform 30 maximal breaths 2 times a day for 
5 days a week (35), IFRL is performed 3 times per week using the Test of Incremental 
Respiratory Endurance (TIRE) (30).  The TIRE protocol has been used and previously described 
by Mickleborough et al. and significantly increased inspiratory muscle endurance (43.9%) and 
strength (26.6%) (29).   
 One of the major advantages of the TIRE protocol is that the subjects perform the 
training until failure.  The protocols followed in studies that utilize IPTL do not require their 
subjects to train until failure.  By exercising to failure they are maximizing the rate of protein 
synthesis for up to 24 hours post-training (4).  It also allows the inspiratory muscles to have an 
adequate amount of recovery time. 
5.3 Normobaric vs. Hypobaric Hypoxia 
51 
 
This study was performed in normobaric hypoxia, but in practicality, athletes compete in 
hypobaric hypoxia.  Saugy et al. (37) examined the physiological and performance differences 
between normobaric hypoxia (NH) and hypobaric hypoxia (HH).  The duration of the time trial 
performance in that study was significantly increased during hypobaric hypoxia compared to 
normobaric hypoxia.  The HH condition had a significantly lower SaO2 than the NH condition, 
which probably caused the decrement in performance based on our knowledge that the defense 
of SaO2 during exercise is strongly linked to endurance performance (5).  Based on these 
differences in performance between NH and HH, we speculate, based on our study outcomes, 
that the effects of IMT on performance in hypobaric hypoxia may be even greater than the 
improvements seen in our study (37).  Further research needs to be performed examining IMT 
and hypobaric hypoxia to determine how much the effects are enhanced from NH to HH.  
  5.4 Limitations 
 As with any training study, there are aspects of subject compliance that can ultimately 
affect performance outcomes.  For example, subjects were asked to self-report their training 
regimens, abstain from alcohol, caffeine and food prior to testing, but we cannot be completely 
certain that these requests were actually followed.  The subjects were asked to record everything 
consumed in the 3 hours prior to their pre-test.  Prior to their post-test we reminded the subjects 
of what they consumed and asked them to consume the type and quantity of food and beverage 
prior to the post-test.  It is possible that the subjects did not report everything consumed prior to 
the pre-test or did not consume everything we told them to consume prior to the post-test.  
However, we were able to control for hydration status by measuring their urine specific gravity 
before all performance trials. 
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 The subjects performed the IMT outside of the laboratory without any supervision.  Even 
though we were able to track their results through the app it is possible that they incorrectly 
performing the IMT.  For example, a couple common mistakes are performing the training with a 
baseline MIP breath that is not a true representation of their MIP, or they might have terminated 
individual training sessions prior to fatigue.  If the training was performed incorrectly it has the 
capability to skew the data. 
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Conclusion 
 The major finding of this study was that 6 weeks of IMT significantly improved 
endurance exercise performance at a simulated moderate altitude in highly trained subjects.  
Based on this research, athletes who are competing in an acute hypoxic environment should 
consider performing 6 weeks of IMT prior to the competition.  IMT prior to altitude exposure 
could also be useful to athletes who are performing altitude training, by maximizing their ability 
to train at altitude.  One of the concerns with altitude training is that athletes are unable to 
perform the same intensity and duration of training as they would in a normoxic environment, 
but with 6 weeks of IMT prior to the altitude training they would be able to increase their 
training load to durations and intensities closer to what they would do in normoxia.   
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Supplement Material 
Appendix I: Variable Key 
Group  1 = IMT 2= Sham  
M  V̇O2max test 
1  Pre-test 
2  Post-test 
Pr  Before V̇O2max or time trial 
Po  Post V̇O2max or time trial 
H  Height 
W  Weight 
vo2R  Relative V̇O2 
vo2A  Absolute V̇O2 
FL  Percent flow Limited 
FLP Percent of V̇O2max at which they become FL 
FVC  Functional vital capacity 
FEV Forced expiratory velocity for 1 second 
FEF  Forced expiratory flow 25-75% 
PEF  Peak expiratory flow 
BIA  Bioelectrical impedance analysis 
SG  Urine specific gravity 
TLC  Total lung capacity 
VC   Vital capacity 
FRC  Functional residual capacity 
IC  Inspiratory capacity 
RV  Residual Volume 
DLCO  Lung diffusing capacity 
DL/VA Lung diffusing capacity divided by alveolar 
volume 
MIP Maximal inspiratory pressure 
MEP Maximal expiratory pressure 
Best Highest MIP average between Pr and Po 
4 4km segment 
8 8km segment 
12 12km segment 
16 16km segment 
20 20km segment 
FH First half average 
SH Second half average 
TA Average for whole 20km TT 
Ve Ventilation 
BPM Breaths per minute 
t  Time 
Sat Arterial oxygen saturation 
Dyp Dyspnea  
RPE  Rate of perceived exhaustion 
Pwr  Power 
Compliance Percent of training sessions completed 
Pre  Initial training session 
Post  Final training session 
Fit  Fit score from PrO2 
PC  Power curve from PrO2 
FiLe  Final level achieved during training session 
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Appendix II: Raw Data 
 
Subject Age group HM WM vo2RM vo2MA FL FLP FVCMpr FEVMpr FEFMpr PEFMpr 
R1101 27 1 173.30 73.34 59.20 4.34             
R1104 21 1 184.90 83.30 62.10 5.18 48.00 100.00 6.63 5.40 5.59 8.21 
R1119 24 1 176.00 76.10 50.40 3.84 no   5.88 4.95 4.97 11.39 
R1120 24 1 180.00 74.90 71.00 5.32 no   6.65 4.82 3.63 9.85 
R1123 21 1 187.00 73.19 64.90 4.75 no   6.20 4.43 3.48 8.66 
R1126 19 1 160.30 50.50 69.00 3.48 no   4.95 3.69 3.03 6.77 
R1129 22 1 181.50 80.73 51.80 4.18 no   6.52 5.61 6.16 8.42 
R1131 21 1 186.00 86.20 79.20 6.83 no   6.61 5.31 5.23 8.52 
R1102 20 2 171.60 67.20 66.80 4.49 44.00 92.00 4.78 3.93 4.06 8.96 
R1105 21 2 170.00 70.70 59.30 4.19 44.00 87.00 4.76 3.84 3.58 8.05 
R1113 21 2 182.20 72.60 65.00 5.05 no   4.63 4.01 4.39 7.06 
R1114 19 2 177.50 74.80 61.90 4.63 38.00 95.00 5.50 4.71 5.10 10.24 
R1117 24 2 177.00 71.40 55.40 3.96 23.80 94.04 5.38 4.80 6.40 12.31 
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Subject FVCMpo FEVMpo FEFMpo PEFMpo H1 W1 BIA1 SG1 FVC1pr FEV1pr FEF1pr PEF1pr 
R1101         172.20 73.21 19.50 1.01 5.00 4.19 4.87 11.88 
R1104 6.42 5.19 5.17 8.35 185.60 85.37 14.20 1.00 6.52 5.25 5.07 9.35 
R1119 5.17 4.82 7.13 10.88 177.30 75.50 12.90 1.01 5.76 4.98 5.35 12.84 
R1120 6.64 4.79 3.59 9.55 179.30 75.69 11.90 1.01 7.03 5.20 4.11 10.17 
R1123 5.98 4.35 3.46 8.76 185.80 74.30 8.00 1.00 6.29 4.56 3.39 9.58 
R1126 5.96 5.08 5.27 9.24 160.30 53.71 8.90 1.00 4.61 3.21 2.29 6.95 
R1129 4.31 3.30 2.75 7.46 181.50 78.85 12.50 1.01 6.02 4.94 4.78 9.72 
R1131         186.00 86.60 13.70 1.02 6.49 5.29 4.96 9.76 
R1102 4.74 4.03 4.22 6.41 172.60 68.70 11.50 1.00 4.91 4.03 3.97 9.70 
R1105 4.68 3.73 3.47 8.21 170.00 72.80 17.70 1.01 4.77 3.57 2.87 8.26 
R1113 4.26 3.75 4.93 7.33 183.60 73.90 10.90 1.02 5.28 4.38 5.24 10.49 
R1114 5.40 4.71 5.14 10.12 177.00 76.43 9.70 1.00 5.31 4.74 5.30 10.89 
R1117 5.33 4.82 6.48 12.63 176.30 71.25 13.20 1.05 5.57 4.99 6.53 14.96 
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Subject TLC1 VC1 FRC1 IC1 RV1 DLCO1 DL/VA MIP1pr MEP1pr FVC1po FEV1po FEF1po 
R1101 5.68 4.83 2.62 3.05 0.84 28.50 4.79 118.00 126.00 4.92 4.22 5.18 
R1104 8.63 6.49 4.27 4.36 2.14 37.10 4.83 174.00 186.50 6.35 5.12 4.84 
R1119 6.64 5.86 2.68 3.97 0.79 37.00 5.23 149.33 125.67 5.80 5.18 5.98 
R1120 7.93 6.87 2.27 5.67 1.06     108.00 187.00 6.97 5.05 3.77 
R1123 8.37 6.49 4.50 3.87 1.88 41.60 5.51 154.00 227.00 6.68 4.79 3.84 
R1126 5.47 4.48 2.59 2.88 1.00 29.85 5.29 54.00 93.33 4.37 3.03 2.16 
R1129 7.10 6.08 2.98 4.12 1.02 38.50 5.06 100.00 146.00 5.51 4.93 5.63 
R1131   5.84   3.87   55.70 6.15 123.00 124.00 6.61 4.32 4.02 
R1102 5.96 4.93 2.08 3.87 1.03 34.20 5.59 149.50 156.30 4.50 3.93 4.48 
R1105 5.29 4.67 1.63 3.66 0.61 32.90 5.40 127.67 178.33 4.45 3.02 1.93 
R1113 6.41 4.53 3.32 3.08 1.88 35.00 6.38 125.00 98.30 5.34 4.57 5.58 
R1114 7.27 5.23 3.65 3.62 1.85 33.80   132.00 105.00 4.89 4.77 5.86 
R1117 7.58 5.58 3.74 3.84 2.00 41.90 6.11 148.00 166.00 5.71 5.23 6.99 
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Subject PEF1po MIP1po MEP1po MIPbest1 vo2R14 vo2A14 ve14 BPM14 hr14 pwr14 t14 sat14 
R1101 1.15 125.00 114.00 126.00 41.50 3.04 96.41 55.00 130.00 174.00 7.73 95.00 
R1104 9.71 176.30 183.67 176.30 52.00 4.44 121.00 47.00 139.00 251.00 6.63 82.00 
R1119 12.05 159.00 122.50 159.00 37.46 2.83 72.58 33.00 153.00 131.00 8.55 87.00 
R1120 9.87 104.30 175.00 108.00 51.89 3.93 121.83 44.00 140.00 232.00 6.87 88.00 
R1123 8.55 158.00 235.70 158.00 41.30 3.07 81.50 27.00 140.00 233.00 6.88 88.00 
R1126 6.70 59.67 89.67 59.67 55.17 2.96 88.37 39.00 156.00 203.00 7.19 87.00 
R1129 9.15 96.00 179.00 100.00 45.70 3.60 136.40 47.00 169.00 252.00 6.62 87.00 
R1131 6.93 132.33 115.67 132.33 41.30 3.58 88.60 24.00 150.00 235.00 6.79 91.00 
R1102 9.11 157.00 216.50 157.00 43.30 2.98 69.30 33.00 150.00 133.00 8.48 89.00 
R1105 7.69 133.00 154.00 133.00 51.12 3.72 111.26 40.00 164.00 176.00 7.65 91.00 
R1113 8.38 129.70 132.30 129.70 49.98 3.69 99.30 47.00 142.00 187.00 7.42   
R1114 9.47 89.00 115.50 132.00 58.30 4.45 151.00 59.00 163.00 197.00 7.27   
R1117 13.55 168.00 152.00 168.00 51.80 3.70 113.70 54.00 148.00 183.00 7.44 87.00 
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Subject dyp14 rpe14 vo2R18 vo2A18 ve18 BPM18 hr18 pwr18 t18 sat18 dyp18 rpe18 
R1101 3.00 16.00 35.61 2.61 76.41 45.00 137.00 137.00 8.39   3.00 17.00 
R1104 5.00 13.00 52.00 4.44 118.10 47.00 151.00 230.00 6.82 81.00 6.00 14.00 
R1119 4.00 13.00 40.78 3.02 82.61 38.00 163.00 131.00 8.58 88.00 5.00 15.00 
R1120 6.00 14.00 53.90 4.08 120.49 49.00 152.00 222.00 6.92 86.00 7.00 17.00 
R1123 4.00 14.00 44.60 3.32 92.30 33.00 150.00 221.00 6.94 86.00 5.00 15.00 
R1126 3.00 11.00 52.40 2.81 85.84 45.00 160.00 180.00 7.49 89.00 3.00 13.00 
R1129 6.00 14.00 45.70 3.62 117.40 41.00 161.00 217.00 6.96 86.00 7.00 16.00 
R1131 2.00 13.00 41.60 3.60 101.10 27.00 164.00 252.00 6.58 90.00 4.00 15.00 
R1102 2.00 11.00 50.50 3.47 93.10 34.00 167.00 162.00 7.85 79.00 3.00 12.00 
R1105 4.00 12.00 51.13 3.72 113.67 48.00 174.00 181.00 7.48 90.00 4.00 12.00 
R1113 6.00 14.00 40.38 2.98 72.00 40.00 142.00 186.00 7.39   7.00 16.00 
R1114 5.00 11.00 54.80 4.19 133.90 58.00 175.60 195.00 7.28   5.00 14.00 
R1117 5.00 15.00 55.30 3.95 114.60 56.00 148.00 183.00 7.45 87.00 7.00 7.00 
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Subject vo2R112 vo2A112 ve112 BPM112 hr112 pwr112 t112 sat112 dyp112 rpe112 vo2R116 
R1101 37.31 2.73 78.72 47.00 130.00 118.00 8.90 96.00 3.00 18.00 37.08 
R1104 49.30 4.21 106.90 47.00 151.00 215.00 7.01 81.00 6.00 14.00 49.20 
R1119 53.77 3.30 92.26 46.00 167.00 148.00 8.12 88.00 7.00 16.00 40.33 
R1120 53.99 4.09 115.07 50.00 151.00 210.00 7.08 87.00 7.00 17.00 55.40 
R1123 46.40 3.45 96.30 30.00 157.00 234.00 6.78 86.00 6.00 17.00 47.80 
R1126 48.80 2.62 79.51 47.00 159.00 164.00 7.78 90.00 3.00 13.00 49.11 
R1129 42.60 3.36 102.70 38.00 155.00 209.00 7.07 84.00 7.00 16.00 40.50 
R1131 42.40 3.67 100.50 28.00 165.00 238.00 6.74   3.00 14.00 41.50 
R1102 55.70 3.83 116.70 47.00 183.00 206.00 7.11 88.00 4.00 14.00 58.60 
R1105 53.28 3.88 120.53 49.00 173.00 179.00 7.52   6.00 13.00 51.65 
R1113 37.57 2.77 70.40 42.00 146.00 198.00 7.25   7.00 17.00 43.45 
R1114 55.10 4.21 145.00 69.00 183.00 212.00 7.07   7.00 16.00 58.10 
R1117 54.20 3.87 114.80 62.00 143.00 169.00 7.69 88.00 7.00 17.00 54.80 
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Subject vo2A116 ve116 BPM116 hr116 pwr116 t116 sat116 dyp116 rpe116 vo2R120 vo2A120 
R1101 2.71 76.20 47.00 126.00 105.00 9.32 96.00 2.00 19.00 37.51 2.75 
R1104 4.20 104.90 46.00 148.00 203.00 7.15 81.00 6.00 16.00 37.40 3.19 
R1119 3.04 80.00 43.00 161.00 121.00 8.80 87.00 8.00 17.00 48.77 3.68 
R1120 4.19 116.10 50.00 153.00 209.00 7.06 86.00 8.00 18.00 58.87 4.46 
R1123 3.56 104.30 35.00 163.00 231.00 6.80   7.00 17.00 53.30 3.96 
R1126 2.64 78.07 43.00 157.00 157.00 7.95 88.00 3.00 13.00 54.78 2.94 
R1129 3.19 96.60 35.00 159.00 211.00 7.04 85.00 7.00 16.00 41.20 3.24 
R1131 3.59 109.00 32.00 174.00 257.00 6.53   4.00 15.00 40.60 3.52 
R1102 4.02 138.00 57.00 187.00 210.00 7.07 89.00 7.00 15.00 58.30 4.01 
R1105 3.76 115.85 20.00 179.00 182.00 7.46   7.00 15.00 55.98 4.05 
R1113 3.21 79.86 44.00 156.00 205.00 7.13   8.00 17.00 40.05 2.96 
R1114 4.44 162.70 77.00 184.00 202.00 7.19   8.00 17.00 58.50 4.47 
R1117 3.91 119.90 62.00 147.00 183.00 7.46 91.00 9.00 18.00 60.90 4.34 
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Subject ve120 BPM120 hr120 pwr120 t120 sat120 hr1FH pwr1FH t1FH hr1SH pwr1SH t1SH 
R1101 85.34 55.00 123.00 100.00 9.52 95.00 133.00 147.00 20.58 126.00 105.00 23.28 
R1104 100.80 59.00 154.00 238.00 6.76 81.00 146.00 236.00 16.92 151.00 218.00 17.45 
R1119 126.18 59.00 160.00 172.80 7.66 90.00 160.00 132.00 21.30 161.00 148.00 20.41 
R1120 128.89 57.00 157.00 219.00 6.97 86.00 147.00 224.00 17.32 154.00 213.00 17.58 
R1123 124.40 40.00 168.00 255.00 6.62   147.00   17.21 165.00   16.81 
R1126 90.38 48.00 168.00 171.00 7.68 82.00   187.00 18.49   162.00 19.54 
R1129 116.80 47.00 171.00 236.00 6.75 84.00   229.00 17.11   220.00 17.33 
R1131 135.10 41.00 185.00 286.00 6.26     242.00 16.74   264.00 16.16 
R1102 148.30 62.00 188.00 212.00 7.09 87.00 163.00 158.00 19.87 187.00 209.00 17.73 
R1105 144.68 61.00 185.00 193.00 7.30   170.00 178.00 18.91 180.00 186.00 18.50 
R1113 77.60 49.00 166.00 237.00 6.76   142.00 186.00 18.52 159.00 202.00 6.76 
R1114 164.80 74.00 189.00 204.00 7.15   172.00 200.00 18.08 186.00 205.00 17.88 
R1117 156.40 82.00 154.00 206.00 7.12 88.00 148.00 179.00 18.77 148.00 190.00 18.39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
 
Subject Dyp1A RPE1A vo2R1TA vo2A1TA ve1TA BPM1TA hr1TA pwr1TA t1TA H2 W2 
R1101 2.75 17.50 38.59 2.83 86.24 50.00 129.00 125.00 43.86 174.00 72.08 
R1104 5.75 14.25 49.50 4.23 113.70 48.20 149.00 227.00 34.37 185.00 82.04 
R1119 6.00 15.25 40.26 3.04 82.00 40.20 140.00 140.00 41.71 175.00 76.20 
R1120 7.00 16.50 53.97 4.09 117.24 48.00 151.00 219.00 34.90 179.00 77.80 
R1123 5.50 15.75 45.20 3.36 95.50 31.30 155.00 235.00 34.02 185.00 74.00 
R1126 3.00 12.50 50.70 2.72 81.80 43.08 160.00 174.00 38.03 160.30 61.62 
R1129 6.75 15.50 43.30 3.41 118.00 41.50 163.00 225.00 34.44 181.50 79.40 
R1131 3.25 14.25 41.20 3.57 102.70 29.00 167.60 253.00 32.90 186.00 85.60 
R1102 4.00 13.00 51.80 3.56 108.40 44.50 174.00 182.00 37.60 172.10 69.64 
R1105 5.25 13.00 51.40 3.74 116.10 47.40 175.00 182.00 37.41 170.50 72.00 
R1113 7.00 16.00 42.60 3.15 80.00 42.30 151.00 202.00 35.95 182.60 73.53 
R1114 6.25 14.50 55.80 4.27 146.70 66.20 179.00 202.00 35.96 176.50 73.80 
R1117 7.00 14.25 54.10 3.85 116.70 61.80 148.00 185.00 37.16 176.80 70.05 
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Subject BIA2 SG2 FVC2pr FEV2pr FEF2pr PEF2pr TLC2 VC2 FRC2 IC2 RV2 DLCO2 
R1101 18.00 1.00 4.81 4.14 5.20 12.39 5.39 4.40 2.56 2.83 1.00   
R1104 12.20 1.00 6.73 5.28 4.83 9.87 8.45 6.73 4.47 3.99 1.72 34.60 
R1119 14.20 1.01 5.86 4.94 5.07 11.37 5.29 5.72 0.73 4.55 0.00   
R1120 13.40 1.02 7.20 5.24 3.96 10.70 8.86 7.34 3.85 5.01 1.52 43.20 
R1123 8.30 1.02 6.71 4.67 3.56 8.31 8.34 6.62 4.57 3.78 1.72 40.90 
R1126 8.70 1.01 4.85 3.40 2.47 7.71             
R1129 15.10 1.03 6.10 4.99 4.91 9.12 6.38 5.62 1.61 4.77 0.76 41.00 
R1131 13.50 1.01 7.46 5.80 4.97 11.60 8.83 6.58 5.06 3.77 2.26 55.55 
R1102 11.50 1.02 4.82 4.03 4.38 8.43 5.14 4.78 1.04 4.11 0.37 27.20 
R1105 15.90 1.02 4.93 3.77 3.13 9.13 5.81 4.84 2.15 3.66 0.97 31.60 
R1113 12.90 1.01 5.31 4.13 3.51 9.48 5.75 5.29 2.24 3.52 0.47   
R1114 12.10 1.01 5.13 4.53 5.15 9.70 6.23 5.04 2.66 3.82 1.19 29.20 
R1117 15.60 1.01 5.53 4.96 6.66 13.25 7.22 5.52 3.61 3.61 1.70 39.50 
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Subject DL/VA2 MIP2pr MEP2pr FVC2po FEV2po FEF2po PEF2po MIP2po MEP2po MIPbest2 vo2R24 vo2A24 
R1101   160.70 165.70 4.86 4.24 4.50 11.92 127.00 127.70 160.70 42.67 3.08 
R1104 4.51 213.75 229.67 2.27 5.08 4.88 9.64 218.67 224.33 218.67 54.34 4.46 
R1119   188.70 137.30 5.44 4.91 5.59 11.30 176.30 150.30 188.70 44.96 3.43 
R1120 4.99 112.70 217.00 7.34 5.37 4.04 11.24 114.00 208.70 114.00 58.00 4.51 
R1123 5.43 175.70 213.70 6.52 4.86 4.12 8.48 177.00 227.50 177.00 43.60 3.23 
R1126   96.67 92.00 4.31 3.30 2.75 7.46 103.00 99.00 103.00 45.86 3.04 
R1129 5.28 101.00 178.33 5.96 5.08 5.27 9.24 97.67 163.33 101.00 45.94 3.65 
R1131 6.02 138.33 198.33 6.57 5.80 5.97 10.04 184.00 160.50 184.00 49.30 4.22 
R1102 4.62 171.70 243.00 4.51 3.90 4.61 8.12 173.00 222.67 173.00 43.71 3.04 
R1105 5.13 105.67 178.33 4.53 3.49 3.06 7.60 122.33 249.00 122.33 50.63 3.65 
R1113   139.30 120.30 5.29 4.54 4.57 10.54 139.30 132.70 139.30 41.98 3.09 
R1114 4.73 132.30 91.00 4.76 4.43 5.41 9.45 122.67 91.33 132.30 57.85 4.27 
R1117 5.75 187.70 191.00 5.58 4.97 7.29 12.02 168.00 188.00 187.70 51.15 3.58 
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Subject ve24 BPM24 hr24 pwr24 t24 sat24 dyp24 rpe24 vo2R28 vo2A28 ve28 BPM28 
R1101 115.72 71.00 144.00 185.00 7.52 92.00 4.00 17.00 39.38 2.84 100.77 62.00 
R1104 121.37 47.00 146.00 239.00 6.74 84.00 4.00 12.00 51.12 4.90 103.08 46.00 
R1119 87.17 38.00 163.00 170.00 7.71 86.00 5.00 15.00 46.61 3.55 101.22 50.00 
R1120 158.10 51.00 152.00 251.00 6.65 88.00 6.00 13.00 56.30 4.38 148.20 56.00 
R1123 88.40 35.00 131.00 200.00 7.22 90.00 2.00 11.00 46.80 3.46 91.70 32.00 
R1126 94.48 44.00 155.00 97.00 7.24 90.00 3.00 12.00 46.97 3.11 98.33 51.00 
R1129 124.20 44.00 156.00 242.00 6.72 87.00 7.00 15.00 44.63 3.54 114.90 43.00 
R1131 117.61 29.00 162.00 258.00 6.58 88.00 4.00 14.00 49.95 4.27 120.09 29.00 
R1102 81.23 35.00 150.00 165.00 7.84 91.00 3.00 12.00 51.24 3.57 103.70 43.00 
R1105 114.24 41.00 146.00 193.00 7.34 91.00 4.00 11.00 49.87 3.59 102.42 45.00 
R1113 85.65 48.00 149.00 176.00 7.60 92.00 4.00 14.00 46.80 3.44 98.97 54.00 
R1114 139.60 59.00 157.00 201.00 7.26   5.00 13.00 55.64 4.11 129.62 62.00 
R1117 103.20 49.00 154.30 198.00 7.28 92.00 7.00 15.00 51.90 3.63 105.50 54.00 
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Subject hr28 pwr28 t28 sat28 dyp28 rpe28 vo2R212 vo2A212 ve212 BPM212 hr212 pwr212 
R1101 141.00 135.00 8.42 93.00 4.00 17.00 33.41 2.41 69.23 44.00 139.00 120.00 
R1104 146.00 210.00 7.06 84.00 4.00 14.00 51.84 4.25 104.01 43.00 146.00 210.00 
R1119 175.00 168.00 7.69 87.00 7.00 17.00 41.71 3.18 85.94 46.00 173.00 138.00 
R1120 168.00 226.00 6.87 86.00 7.00 15.00 55.60 4.33 147.10 54.00 171.00 223.00 
R1123 148.00 212.00 7.04 91.00 3.00 13.00 51.20 3.79 107.70 41.00 161.00 231.00 
R1126 163.00 192.00 7.31 89.00 3.00 12.00 46.94 3.11 100.24 52.00 166.00 187.00 
R1129 163.00 218.00 6.95 87.00 7.00 15.00 43.10 3.42 102.50 39.00 163.00 214.00 
R1131 169.00 262.00 6.49 86.00 4.00 14.00 50.56 4.33 133.14 33.00 171.00 253.00 
R1102 170.00 192.00 7.32 89.00 4.00 13.00 53.23 3.70 116.17 50.00 182.00 201.00 
R1105 153.00 189.00 7.36 90.00 5.00 13.00 49.18 3.54 107.46 49.00 155.00 178.00 
R1113 158.00 191.00 7.32 90.00 6.00 15.00 48.01 3.53 100.85 52.00 163.00 196.00 
R1114 167.00 198.00 7.24   5.00 14.00 53.39 3.94 122.05 61.00 167.00 176.00 
R1117 167.00 197.00 7.25 93.00 7.00 15.00 52.92 3.70 105.30 59.00 168.30 189.00 
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Subject t212 sat212 dyp212 rpe212 vo2R216 vo2A216 ve216 BPM216 hr216 pwr216 t216 sat216 
R1101 8.83 94.00 4.00 19.00 33.89 2.44 65.80 41.00 127.00 102.00 9.43 92.00 
R1104 7.06 84.00 5.00 15.00 49.51 4.06 100.74 45.00 148.00 210.00 7.05 84.00 
R1119 8.34 88.00 8.00 17.00 45.10 3.44 96.30 48.00 174.00 139.00 8.29 88.00 
R1120 6.92   7.00 15.00 55.70 4.34 152.40 55.00 172.00 219.00 6.97   
R1123 6.80 84.00 5.00 15.00 52.40 3.88 114.50 44.00 167.00 236.00 6.74 84.00 
R1126 7.39 91.00 4.00 14.00 41.10 2.72 84.58 48.00 164.00 176.00 7.55 90.00 
R1129 7.01 86.00 8.00 17.00 43.08 3.42 101.80 38.00 164.00 212.00 7.03 87.00 
R1131 6.58 88.00 5.00 15.00 51.45 4.40 145.39 39.00 178.00 255.00 6.54 87.00 
R1102 7.18 89.00 5.00 15.00 54.14 3.77 123.70 54.00 186.00 202.00 7.31 88.00 
R1105 7.52 91.00 7.00 14.00 46.32 3.33 98.57 50.00 149.00 156.00 7.95 93.00 
R1113 7.25 90.00 7.00 17.00 45.24 3.33 94.15 49.00 168.00 192.00 7.30 90.00 
R1114 7.66   7.00 17.00 55.99 4.13 140.82 71.00 169.00 186.00 7.42   
R1117 7.35 92.00 7.00 15.00 50.68 3.55 101.90 59.00 166.30 180.00 7.48   
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Subject dyp216 rpe216 
vo2R22
0 vo2A220 ve220 
BPM22
0 hr220 
pwr22
0 t220 sat220 hr2FH 
pwr2F
H 
R1101 4.00 19.00 41.82 3.01 90.20 52.00 132.00 117.00 8.92 93.00 142.00 152.00 
R1104 6.00 15.00 62.76 5.15 172.01 63.00 155.00 246.00 6.67 84.00 146.00 222.00 
R1119 9.00 19.00 49.40 3.76 122.80 61.00 175.00 162.00 7.88 87.00 169.00 163.00 
R1120 8.00 16.00 57.50 4.47 161.10 57.00 173.00 228.00 6.87   160.00 238.00 
R1123 6.00 17.00 56.10 4.15 140.00 54.00 174.00 246.00 6.66 85.00 142.00 210.00 
R1126 4.00 14.00 49.81 3.30 114.14 55.00 179.00 207.00 7.10 89.00   193.00 
R1129 8.00 17.00 51.09 4.08 136.60 41.00 169.00 220.00 6.93 87.00 160.00 227.00 
R1131 5.00 16.00 51.84 4.44 160.01 44.00 178.00 268.00 6.43 86.00   259.00 
R1102 7.00 17.00 56.47 3.93 138.05 63.00 187.00 203.00 7.22 89.00 164.00 183.00 
R1105 8.00 14.00 56.22 4.05 142.55 64.00 162.00 191.00 7.34 85.00 151.00 189.00 
R1113 8.00 18.00 52.23 3.84 130.15 60.00 174.00 209.00 7.08 88.00 155.00 188.00 
R1114 8.00 17.00 60.02 4.43 143.55 65.00 171.00 188.00 7.37   162.00 194.00 
R1117 7.00 15.00 56.31 3.94 163.10 80.00 176.00 211.00 7.08 90.00 162.00 196.00 
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Subject t2FH hr2SH 
pwr2S
H t2SH Dyp2A RPE2A 
vo2R2T
A 
vo2A2T
A ve2TA 
BPM2T
A hr2TA 
pwr2T
A 
R1101 20.21 110.00 131.00 22.91 4.00 18.00 37.36 2.69 92.82 57.00 138.00 130.00 
R1104 17.31 150.00 223.00 17.27 4.75 14.00 52.73 4.32 113.65 48.00 148.00 223.00 
R1119 19.55 173.00 147.00 20.36 7.25 17.00 44.40 3.38 93.20 46.00 171.00 155.00 
R1120 16.99 172.00 223.00 17.29 7.00 14.75 55.20 4.29 146.60 52.00 167.00 230.00 
R1123 17.66 152.00 239.00 16.80 4.00 14.00 47.80 3.54 100.20 36.00 147.00 225.00 
R1126 18.24   191.00 18.35 3.50 13.00 45.09 2.99 96.23 49.00 165.40 192.00 
R1129 17.17 166.00 215.00 17.47 7.50 16.00 43.85 3.48 112.50 40.00 163.00 221.00 
R1131 16.33   259.00 16.29 4.50 14.75 49.14 4.21 128.37 33.00 171.60 259.00 
R1102 18.72 185.00 201.00 18.15 4.75 14.25 51.20 3.56 109.64 49.00 173.00 192.00 
R1105 18.43 155.00 173.00 19.08 6.00 13.00 49.71 3.58 109.84 50.00 153.00 181.00 
R1113 18.52 170.00 199.00 18.03 6.25 16.00 45.31 3.33 95.77 51.00 163.00 193.00 
R1114 18.31 170.00 183.00 18.64 6.25 15.25 55.37 4.09 130.10 64.00 167.00 188.00 
R1117 18.19 170.30 193.00 18.25 7.00 15.00 52.08 3.64 109.50 58.00 166.20 195.00 
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Subject t2TA Compliance Fit_pre PC_pre MIP_pre FiLe_pre Fit_post PC_post MIP_post FiLe_post 
R1101 43.12 88.89 58.50 940.00 93.00 26.00         
R1104 34.58 83.33 62.80 1242.00 155.00 31.00 64.40 1321.00 165.00 38.00 
R1119 39.91 88.89 85.80 1177.00 127.00 36.00 87.00 1225.00 133.00 39.00 
R1120 34.28 83.33     112.00       138.00   
R1123 34.46 100.00     175.00       193.00   
R1126 36.59                   
R1129 34.64 88.89 29.30 530.00 87.00 20.00 23.60 459.00 88.00 37.00 
R1131 32.62 72.22 89.00 1294.00 124.00 42.00 152.50 1937.00 196.00 28.00 
R1102 36.87 77.78 29.00 602.00 99.00 19.00 30.60 652.00 95.00 26.00 
R1105 37.51 83.33 40.30 814.00 134.00 42.00 20.50 643.00 142.00 41.00 
R1113 36.55 100.00 16.00 439.00 86.00 42.00 20.70 601.00 135.00 40.00 
R1114 36.95 77.78 24.30 564.00 109.00 42.00 21.00 595.00 116.00 22.00 
R1117 36.44 94.44 44.70 810.00 149.00 41.00 38.70 741.00 143.00 42.00 
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Appendix III: General Study Questionnaire  
General Study Questionnaire 
Name Date 
 
Do you consider yourself to be a highly endurance trained 
individual? 
(Circle one)                   YES                         NO 
On average, how many days per week do you typically 
complete a cycle workout? 
 
On average, how many minutes do you cycle in a typical 
week? 
 
  
  
 
Participant Signature Date 
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Appendix IV: PAR-Q 
Modified Physical Activity Readiness Questionnaire (PAR-Q) 
Name Date 
DOB Age Home Phone Work Phone 
Regular exercise is associated with many health benefits, yet any change of activity may increase the risk of injury. Please read each question carefully and 
answer every question honestly: 
Yes No 1. Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor? 
Yes No 2. Do you feel pain in your chest when you do physical activity? 
Yes No 3. In the past month, have you had chest pain when you were not doing physical activity? 
Yes No 4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
Yes No 5. Do you have a bone or joint problem that could be made worse by a change in your physical activity? 
Yes No 6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition? 
Yes No 7. Do you know of any other reason you should not do physical activity? 
Yes No 8. Has your doctor ever told you that you have diabetes?  
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Yes No 9. Has your doctor ever told you that you have high blood pressure?  
Yes No 10. Has your doctor ever told you that you have high cholesterol?  
Yes No 11. Has your doctor ever told you that you have high blood sugar?  
Yes No 12. Do you smoke? 
Yes No 13. Are you currently inactive?  
Yes No 14. Do you have a father, brother or son with heart disease before the age of 55 years old or a mother, sister or daughter with heart disease before the age of 65 years old? 
15. (Researcher will complete)  Measure height and weight to determine BMI:        
Height:________                                                                  
Weight:________                                                           
 
Participant Signature Date 
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INDIANA UNIVERSITY INFORMED CONSENT STATEMENT FOR 
 
The Effect of Inspiratory Muscle Training on Exercise Performance in Hypoxia 
 
You are invited to participate in a research study that will help determine if inspiratory muscle training (training the breathing muscles) can help 
improve exercise performance in hypoxia (low oxygen content of the air). You were selected as a possible subject because of your status as a 
highly trained cyclist. We ask that you read this form and ask any questions you may have before agreeing to be in the study. 
 
Disclaimer: It is possible that after completing the study questionnaires and the initial exercise test that you will not qualify for the study. 
 
The study is being conducted by Robert F. Chapman, Ph.D. (Principal Investigator), and co-investigators Daniel Hursh and Timothy 
Mickleborough, Ph.D. in the Department of Kinesiology at Indiana University-Bloomington. 
 
STUDY PURPOSE 
 
The purpose of the proposed study is to investigate if inspiratory muscle training (breathing in against a resistance) will help to improve exercise 
performance in a low oxygen environment, like what exists at altitude. 
 
NUMBER OF PEOPLE TAKING PART IN THE STUDY: 
 
If you agree to participate, you will be one of approximately 24 subjects who will be participating in this research. 
 
PROCEDURES FOR THE STUDY: 
 
If you agree to be in the study, the following items are included: 
 
An invitation will be extended to visit the Human Performance laboratory on four occasions at a previously agreed-upon time. Each visit will last 
approximately 60 minutes. You will also be asked to complete a “real” or “fake” inspiratory muscle training protocol in your home on three days a 
week, over the course of six weeks. These home inspiratory muscle training sessions will last approximately 8-15 minutes. Finally, you will be 
asked to complete an online training log of your cycling workouts, which will take approximately 2 minutes each day. 
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The initial laboratory testing session (Session 1) includes completion of two written questionnaires, measures of your height and weight, measure 
of your body composition (fat and lean weight), and a maximal exercise test on a cycle ergometer (a stationary bike). A maximal exercise test is 
where you exercise at efforts become harder each minute, until you become too tired to continue. The remaining three laboratory sessions 
(Sessions 2, 3, and 4) include measures of your resting pulmonary function (breathing tests) and a 20km (about 12.5 mile) all out time trial on a 
cycle ergometer. 
 
Each of these tests is described below. 
 
Height and weight measures.  Height will be measured by asking you to stand against a wall and a device will be lowered until it touches the top 
of your head. Weight will be measured by having you sit on a chair, which is placed on a scale. This test will be completed in both visits to the lab. 
 
Body composition measures. You will be asked to stand on a scale in bare feet and hold two handles connected to the scale. A small, electrical 
current which you will not be able to feel will pass through your body for about two seconds. The scale will calculate an estimate of the percent of 
your weight that is lean weight and the percent that is fat weight. This test will be completed only on the first visit to the lab. 
 
Resting pulmonary function (breathing tests). You will be asked to sit in a chair and rest comfortably for 10 minutes. You will be asked to put 
nose clips on your nose and breathe through a plastic mouthpiece. The nose clips are cleaned in detergent and an antibacterial solution after each 
use, and the plastic mouthpiece is new for each subject. While sitting in the chair, you will be asked to complete various breathing tests which 
measure the size of your lungs, how fast you can move air in and out of your lungs, the ability of your lungs to transfer gas to the blood, and the 
ability of your lungs to generate pressure. 
 
Cycle Tests. These exercise tests will be completed on a cycle ergometer. One test is a maximal exercise test and the other is a 20km time trial. 
For all cycle tests, you will be allowed to warm up on the cycle ergometer for 10 minutes at any pedaling rate and resistance you would like to 
select. A strap will be placed around your chest which will measure your heart rate. A small sensor will be placed on your forehead that measures 
the amount of oxygen in your blood. Another sensor will be placed on your thigh and secured with an elastic bandage. You will be asked to 
complete the cycle tests while breathing through a face mask which covers your nose and mouth. Air will flow into and out of your lungs as you 
breathe through the face mask. The face mask, forehead sensor, thigh sensor, and heart rate monitor are cleansed in a detergent and antibacterial 
solution following each use. 
 
For the maximal exercise test, the initial workload will be set at 100W, and you will be asked to maintain a pedaling rate between 80 and 110 
RPMs throughout the test. Every minute, the workload will increased by 25W until you become so tired that you need to stop, or your cadence 
drops below 70 RPM for three seconds. The goal is to pedal for as long as you can, with a typical test lasting between 10 and 15 minutes. 
 
For the 20km time trials, you can pedal at any pedaling rate you like and set the resistance / gearing at any level you like. The goal is for you to 
complete a 20km ride in as short of a time as possible. You will be given real time feedback of the distance you have completed on a video 
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monitor, as well as verbal feedback of distance completed every 4km. For these 20km time trials, the air you breathe in will have a reduced 
amount of oxygen, which is equivalent to an altitude of 2500m or 8000ft. 
 
Inspiratory muscle training. Between Sessions 3 and 4, you will be asked to complete breathing exercises called inspiratory muscle training 
(abbreviated as IMT below). You will be placed into either: a) a “fake” inspiratory muscle training group that completes breathing exercises at a 
low effort that does not cause the breathing muscles to get stronger, or b) a “real” inspiratory muscle training group that completes breathing 
exercises at an effort which causes the breathing muscles to get stronger. Half of the subjects who agree to participate in the study will be placed 
randomly in each group, and you will not be told which group you are placed. 
 
For both groups, you will be asked to complete six weeks of real or fake IMT. You will be asked to complete three IMT sessions a week, with at 
least 48 hours between sessions. You will be given a handheld IMT device to take home and you will be asked to download a smartphone app 
which pairs via Bluetooth with the IMT device. The daily IMT procedure starts with three maximal effort inspirations against a resistance for 
about 12-15 seconds. From these maximal inspirations, the smartphone app will draw a graph on the screen which shows a target inspiratory 
pressure to try and meet during the remainder of the training session. You will then be asked to complete the day’s training by inspiring against a 
set amount of resistance in an attempt to match the graph displayed on the app. The resistance will be set to either 80% (real IMT group) or 15% 
(fake IMT group) of your maximal inspiratory pressure, and you will not be told which level of resistance is set on the IMT device. After a rest 
period of between 15 and 60 seconds, you will be asked to complete additional inspiratory repetitions until the app indicates that you were unable 
to inspire within 10% of the required pressure. A typical IMT session includes 6-18 inhalations and takes between 8 and 15 minutes. Before you 
leave the lab with the device for the first time, an investigator from our study will teach you how to use the device correctly and follow the 
procedures listed above. You will have an opportunity to practice this in the lab, and investigators from our study can monitor how well you are 
doing remotely through the smartphone app. 
 
Cycle training log. You will be given a link to an online training log, where we will ask you to record the number of minutes cycled each day and 
a subjective rating of the effort of the training session. It is estimated that this will take approximately 2 minutes per day. 
 
RISKS OF TAKING PART IN THE STUDY: 
 
While in the study, the risks are: 
 
Submaximal (low and moderate effort) and maximal (all-out effort) exercise tests of healthy individuals, as described by the American College of 
Sports Medicine, present little risk to the subject and do not require medical clearance for subjects under the age of 40. Potential risks and/or 
discomforts can include episodes of temporary light-headedness, chest discomfort, leg cramps, occasional irregular heartbeats, and abnormal blood 
pressure responses. The risk of heart attack, although minor, (approximately 1 to 2 in 10,000) does exist. One death occurs for roughly every 
880,000 man hours of submaximal exercise in apparently healthy individuals. During the test you will be closely monitored for any abnormal 
changes in heart rate or breathing. You are free to indicate any discomfort and discontinue participation at any time. 
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All face masks will be cleaned in detergent and antibacterial solution after each use, minimizing the risk of virus transmission between subjects. 
 
When breathing the low oxygen gas, you may feel lightheaded, which can be quickly reversed by removing the face mask and breathing room air. 
The low oxygen gas does not have substantial moisture, and may dry out and irritate your throat. 
 
There are no known risks of completing inspiratory muscle training using the IMT device. 
 
There is a potential risk of loss of confidentiality. 
 
BENEFITS OF TAKING PART IN THE STUDY: 
 
The benefits to participation that are reasonable to expect are information regarding your overall level of fitness.  Other than this information, you 
will gain little benefit. All subjects will be provided with feedback concerning their own results and the general findings of the study upon request. 
 
CONFIDENTIALITY 
 
Efforts will be made to keep your personal information confidential. Data will be stored on password protected computers in locked rooms with 
limited public access. We cannot guarantee absolute confidentiality. Your personal information may be disclosed if required by law. Your identity 
will be held in confidence in reports in which the study may be published and databases in which results may be stored.   
 
Organizations that may inspect and/or copy your research records for quality assurance and data analysis include groups such as the study 
investigator and his/her research associates, the IU Institutional Review Board or its designees, and (as allowed by law) state or federal agencies, 
specifically the Office for Human Research Protections (OHRP) who may need to access the collected medical and/or research data. 
 
PAYMENT 
 
Should you qualify for the study, you will be paid a $50 gift card for completing the entire study. Should you quality for the study then withdraw 
from the study for any reason, you will be paid a $20 gift card. Payment is made via a gift card, which will be given to you at the end of your final 
testing session. 
 
COMPENSATION FOR INJURY 
 
In the event of physical injury resulting from your participation in this research, necessary medical treatment will be provided to you at your own 
expense. Costs not covered by your health care insurer will be your responsibility. Also, it is your responsibility to determine the extent of your 
health care coverage. There is no program in place for other monetary compensation for such injuries. However, by signing this form you are not 
giving up any legal rights or benefits to which you are otherwise entitled. 
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CONTACTS FOR QUESTIONS OR PROBLEMS 
 
For questions about the study or a research-related injury, contact the researcher Robert Chapman, Ph.D. at (812) 856-2452 or 
rfchapma@indiana.edu. If you cannot reach the researcher during regular business hours (i.e. 8:00AM-5:00PM), please call the IU Human 
Subjects Office at (812) 856-4242 or (800) 696-2949. 
 
For questions about your rights as a research participant or to discuss problems, complaints or concerns about a research study, or to obtain 
information, or offer input, contact the IU Human Subjects Office at (812) 856-4242 or (800) 696-2949. 
 
VOLUNTARY NATURE OF STUDY 
 
Taking part in this study is voluntary. You may choose not to take part or may leave the study at any time. 
Leaving the study will not result in any penalty or loss of benefits to which you are entitled. Your decision whether or not to participate in this 
study will not affect your current or future relations with the investigators or Indiana University. 
 
Your participation may be terminated by the investigator without regard to your consent in the following circumstances: an abnormal response to 
exercise testing or an inability to complete the exercise tests. 
 
SUBJECT’S CONSENT 
 
In consideration of all of the above, I give my consent to participate in this research study. 
 
I will be given a copy of this informed consent document to keep for my records. I agree to take part in this study. 
 
 
Subject’s Printed Name: ________________________________________________ 
 
Subject’s Signature: ___________________________________________________ 
Date: ________________________________________________________________ 
(must be dated by the subject) 
Printed Name of Person Obtaining Name: ____________________________________ 
 
Signature of Person Obtaining Consent: _____________________________________ 
Date: __________________________________________________________________ 
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